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ABSTRACT
Since its introduction by Inoue in 1984, percutaneous balloon mitral valvotomy (BMV)
has been widely used as an alternative to surgery for the treatment of rheumatic mitral
stenosis. The success of BMV relies heavily on the presence of valve morphology
suitable for balloon dilatation and cardiac ultrasound has become the cornerstone for
assessment of patients undergoing this procedure. In young patients with pliant valves
and predominant commissural fusion, the success of BMV has been well documented
and for such patients this is the treatment of choice. However, with the disappearance of
rheumatic fever in developed countries, patients presenting with mitral stenosis to
centres such as ours are typically elderly. They often have valve anatomy less suitable
for balloon dilatation but surgical risk is also much higher. Experience of BMV in this
population is limited, results are less predictable and the selection of patients less
straightforward.
In a centre with the largest experience ofBMV in the UK, I have reported on a series of
405 consecutive patients, mean age 60.7 years, 27.7% over 70 years old. Longer term
outcome was recorded in 300 patients over 10 years. I studied the anatomical and
clinical characteristics of this diverse group of patients. I evaluated the role ofBMV as a
definitive treatment where echocardiography showed valve anatomy to be suitable for
balloon dilatation and as a palliative option in older patients with severe degenerative
valve disease but high surgical risk. I identified factors predicting immediate
haemodynamic and longer term functional success. I studied in detail the strengths and
limitations of two-dimensional transthoracic, transoesophageal and three-dimensional
echocardiography for the assessment of patients undergoing BMV. Importantly, I have
been able to show that specific evaluation of mitral commissural morphology, a feature
not included in current echocardiography scoring systems, was a powerful predictor of
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1.1 Rheumatic fever: epidemiology and influence on demographics of valvular
heart disease
Mitral stenosis is almost always the result of a previous attack of rheumatic fever,
although in 50% of cases this is subclinical. In many under-developed countries, the
incidence of acute rheumatic fever has increased over the last 50-60 years and exceeds
100 per 100,000 [World Health Organisation 1988], Difficulty in accessing health care
rapidly leads to inadequate treatment of streptococcal sore throat and secondary
prophylaxis is rarely implemented. Moreover, overcrowding and poor living conditions
have accelerated the propagation of the disease. In these areas rheumatic fever adopts a
malignant form and advances rapidly. Recurrent untreated streptococcal infection and
subsequent recurrent rheumatic carditis results in severe mitral stenosis in young patients
and is the commonest cause of acquired heart disease in school age children and young
adults world-wide. Hospital statistics from most developing nations reveal that
approximately 10-35% of all cardiac admissions are for patients with rheumatic fever or
chronic rheumatic heart disease [Narula et al 1999]. Accordingly, valve replacement
accounts for the majority of cardiac surgery in these countries.
In contrast, the incidence of rheumatic fever in the United States and Western Europe
has fallen dramatically over the last century. In the early 1900s during the industrial
revolution, rheumatic fever was still one of the leading causes of morbidity and
mortality perhaps due to overcrowding in urban areas. The annual incidence in the US at
this time was 100-200 cases per 100,000. By the late 1940s the incidence had reduced to
50 per 100,000 and the rate fell further to 0.5 per 100,000 by the early 1980s [Gordis et
al 1985]. In England and Wales there were 81 deaths notified as resulting from
rheumatic fever in 1944, 64 in 1954, 7 in 1964 and 4 in 1975 [Hutchison 1989], This
decline has been attributed to the use of prophylactic penicillin and socio-economic
advances. There was no actual decrease in the incidence of streptococcal pharyngitis per
se; instead there was a disappearance of rheunratogenic strains in the more affluent
communities of developed countries [Stollerman G et al 1997], During 1985-1988, the
medical community in the US were surprised by four unexpected outbreaks of rheumatic
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fever which represented a 20-fold increase in the expected incidence in these areas
[Hosier D et al 1987]. These resurgences may be explained by periodic shifts in the
appearance and resurgence of potent rheumatogenic strains of streptococci, particularly
those belonging to the M serotypes once so prevalent in epidemics of rheumatic fever.
The virtual disappearance of rheumatic fever combined with the ageing of the
population, has altered the prevalence and character of valvular heart disease in the
Europe and North America. Calcific aortic stenosis is now the commonest valve lesion
with a reported prevalence of 4.8% in those aged 75-86 [Lindroos M et al 1993]. Non-
rheumatic degenerative processes more commonly cause mitral valve disease which
usually manifests as mitral regurgitation and rheumatic mitral stenosis is seen less
frequently. However, mitral stenosis may still be encountered amongst the elderly
population. This is because there is a long latent period between acute rheumatic fever
and the development of chronic rheumatic valve disease. Also, patients are presenting
with restenosis a number of years after a previous successful surgical mitral valvotomy.
Furthermore, the immigration from developing countries has meant that mitral stenosis
continues to represent an important clinical entity which should not be overlooked.
1.2 Mitral Stenosis: Pathology
Cardiac involvement by rheumatic fever produces a pancarditis invariably associated
with the murmurs of valvulitis (Carey Coombs murmur) and is therefore easily
diagnosed by auscultation. The infiltration of mononuclear cells leads to formation of
Aschoff nodules in the interstitium of the myocardium and these are considered
pathognomonic of rheumatic carditis. In the acute stage valve lesions are relatively
slight. The initial valvulitis results in verruciform deposition of fibrin along the closing
portion of both leaflets, representing mechanical traumatic injury of the swollen leaflets
. by repetitive closure [Horstkotte D et al 1991]. Progressive scarring may then occur.
Approximately 50% of children with rheumatic fever will develop mitral valvulitis. Less
often the aortic, and occasionally the tricuspid valves are involved, the relative
frequency of involvement being related to the pressure sustained by the valve. The
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subsequent development of mitral stenosis is four times commoner in females than males.
The characteristic feature of chronic rheumatic mitral stenosis is fusion along the line of
apposition between the anterior and posterior mitral leaflets (commissure) producing
restricted leaflet mobility and fish-mouth shaped orifice with reduced area (Figure 1).
Pure commissural fusion with thin, mobile leaflets is seen mostly in younger patients and
responds very well to percutaneous valvotomy where the dominant mechanism is
commissural splitting [Reid C et al 1987]. Other forms of degenerative change include
leaflet thickening and rigidity, tethering and shortening of the chordae tendinae and
leaflet calcification.
Figure 1: mitral valve anatomy
A. Normal mitral valve anatomy in the closed position viewed from the left atrium. The
major commissure (large arrow) is visible between the anterior (Ant) and posterior
(Post) leaflets and has anterolateral (AL) and posteromedial (PM) ends. Minor
commissures (small arrows) divide the posterior leaflet into scallops
B. Mitral stenosis due to symmetrical bilateral commissural fusion.
A B
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1.3 Mitral stenosis: Clinical features
The normal mitral valve area is 4-6 em2. A reduction in valve area to less than 2cm2 is
generally required before initial symptoms of exertional dyspnoea become apparent.
When the valve area is critically reduced to <lcm2, a considerable left atrial pressure is
required to maintain normal cardiac output and pulmonary capillary pressures are
elevated at rest causing dyspnoea. Several hours of increased venous return to the
pulmonary vasculature which occurs when patients are lying horizontally in bed at night,
causes awakening from pulmonary oedema (paroxysmal nocturnal dyspnoea). Cardiac
output is usually depressed at rest and fails to rise with exertion producing weakness and
fatigue. An increase in heart rate markedly augments the transmitral gradient and left
atrial pressure. Therefore, pulmonary oedema can occur precipitously in patients who
suddenly develop atrial fibrillation. The increase in blood volume during pregnancy also
leads to a raised left atrial pressure and dyspnoea at rest.
Wood [Wood P 1954] differentiated between five forms of haemoptysis complicating
mitral stenosis: (1) 'Pulmonary apoplexy' due to sudden rupture of thin walled bronchial
veins. (2) Blood stained sputum associated with paroxysmal nocturnal dyspnoea (3)
Blood stained sputum complicating chronic bronchitis which occurs commonly in the
setting of oedematous bronchial mucosa in patients with mitral stenosis (4) Pink frothy
sputum characteristic of acute pulmonary oedema with rupture of alveolar capillaries.
(5) Frank haemoptysis due to pulmonary infarction, a late complication of mitral
stenosis associated with heart failure.
Systemic thromboembolism from intracardiac thrombus is more likely to occur in
patients with mitral stenosis, 80% of whom are in atrial fibrillation. Prior to the advent
of surgical and anticoagulant therapy, this serious and disabling complication developed
in 20% of patients with mitral stenosis and accounted for one quarter of all fatalities in
patients with mitral valve disease [Braunwald E], Half of all clinically apparent emboli
are found in the cerebral vessels but may also involve the coronary circulation leading to
myocardial infarction and renal vessels causing hypertension. Rarely, a massive ball-
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valve thrombus can occur in the left atrium obstructing mitral inflow. Other
complications of mitral stenosis include infective endocarditis and marked left atrial
dilatation can lead to hoarseness secondary to compression of the left recurrent laryngeal
nerve (Ortners Syndrome).
It probably takes a minimum of 2 years after the onset of rheumatic fever for severe
mitral stenosis to develop, and in temperate areas a latent period of between 10 and 20
years is usual before the onset of symptoms [Bland E et al 1951], This may reflect a
mild initial carditis causing scarring followed by slow progression of valvar
degeneration mediated by non- rheumatic "wear and tear" processes. Alternatively,
decades of a "smouldering" rheumatic valvulitis might explain the delay in symptoms
[Homer C et al 1951] although this theory is less well supported. A further 5 to 10 years
will pass until the patient becomes disabled at which point progression of the disease to
death due to pulmonary oedema and pulmonary hypertension with right ventricular
failure is relatively rapid. The 5 year survival in medically treated patients is 62% for
patients in New York Heart Association (NYHA) symptom class III and only 15% for
those in NYHA class IV [Oleson K et al 1962], Furthermore, a one year mortality of
close to 50% has been reported in patients with mitral stenosis developing congestive
cardiac failure. [Rapaport E 1975]
1.3 Treatment ofmitral stenosis: historical development
There are four possible interventions in patients with symptomatic mitral stenosis
despite optimal medical therapy: (a) Closed surgical commissurotomy, (b) open surgical
commissurotomy, (c) mitral valve replacement and more recently (d) percutaneous
balloon mitral valvotomy.
As with pulmonic valvuloplasty, early surgical experience with the treatment of mitral
stenosis has paved the way for percutaneous balloon dilatation of the mitral valve. In
1923, Elliot Cutler of Boston reported the first successful operative treatment for mitral
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stenosis [Cutler E et al 1923], In a twelve year old girl he performed a median
sternotomy and introduced a curved surgical knife into the left ventricle to cut the
diseased mitral valve. The procedure was completed successfully and the patient
survived for a further 4 and a half years before dying suddenly. However, surgery had
resulted in significant mitral reflux. Believing that mitral regurgitation was tolerated
better than stenosis, Cutler operated on a further six patients using similar techniques,
but all succumbed.
Two years later, Henry Souttar, surgeon to the London Hospital, performed the first
successful mitral valvotomy via the atrial approach [Souttar HS 1925]. In a 19 year old
'thin girl with a bright malar flush' the mitral valve was explored digitally through the
left atrial appendage. Although a commissurotomy incision had been planned, Souttar
detected an unexpected degree of mitral regurgitation and instead used 'digital
separation of adhesions' to dilate the orifice. The patient was symptomatically improved
and lived for 5 years before dying from a cerebral embolus. Souttar concluded in his
report to the British Medical Journal that 'the method of digital exploration through the
auricular appendage cannot be surpassed for simplicity and directness'. However, JH
Powers [Powers JH 1932], one of Cutlers' residents, demonstrated conclusively in
laboratory animals the disastrous implications of mitral regurgitation superimposed on
existing stenosis. Combined with Cutlers own discouraging results, these findings
caused British physicians to discontinue direct operations on cardiac valves and Souttar
was referred no more patients.
A quarter of a century was to pass before Bailey [Bailey CP 1949] in the USA and
Brock [Brock RC 1951] in Britain were to firmly establish closed mitral valvotomy as a
valuable surgical treatment. Bailey used finger palpation of the valve followed by
commissurotomy with a hooked finger knife. Brock was the chief advocate of digital
separation of the fused leaflets and clearly described that that in order to preserve the
integrity and function of the valve, 'enlargement of the narrowed orifice must be made
along the line of the commissures'. In more severely degenerative valves, finger
pressure was not always adequate for dilatation. With the introduction of specially
designed transventricular mechanical dilators by Logan, which were further refined by
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Tubbs, this problem was overcome and closed mitral commissurotomy became a widely
practiced treatment for mitral stenosis. The operation was short, simple and provided
good haemodynamic and long term results in patients with mobile, non-calcified valves
with pure commissural fusion [Ellis L et al 1973].
Following the advent of safe cardiopulmonary bypass, the closed procedure became
replaced in the United States and Europe by open commissurotomy which could be
performed more accurately under direct vision. The open technique provided more
complete commissural incisions, separation of fused chordae, debridement of calcium
and removal of thrombus from the left atrium. Furthermore, if inspection revealed a
valve unsuitable for repair, the surgeon could perform mitral valve replacement. Both
open and closed techniques were associated with an acceptable mortality rate ranging
from 1 to 3 % but open commissurotomy provided better haemodynamic improvement
with fewer embolic complications [Farhat M 1990]. The closed procedure remains
popular in some developing countries where patients with mitral stenosis are younger
with less severe degenerative valve disease and the high cost of cardiac surgery can be
avoided.
Balloon mitral valvotomy (BMV) was first reported in 1984 as an alternative to cardiac
surgery by a Japanese cardiothoracic surgeon [Inoue K 1984], This technique produces a
commissurotomy similar to that achieved by surgery [Kaplan J et al 1987] with
comparable results to open and closed commissurotomy [Farhat M 1998], BMV has the
advantage that it can be performed percutaneously under local anaesthetic thereby
avoiding general anaesthesia, cardiopulmonary bypass and prolonged hospital stay.
Inoue used a novel bilobar rubber-nylon balloon catheter which was introduced via a
transeptal approach. The balloon was self-seating and could be progressively inflated.
With the use of a single balloon, Inoue performed this technique on six patients. Mean
mitral gradient decreased from 18 to 7 mmHg, there was a significant reduction in left
atrial pressure and no major complications.
The Inoue catheter became approved in 1994 and until then this technique was
overshadowed in Western countries by the use of the traditional cylindrical balloons
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adapted from pulmonic valvuloplasty. In 1985, Lock used such cylindrical balloons
successfully in eight children and young adults with mitral stenosis [Lock J et al 1985].
Following this, Al Zaibag introduced the use of a double-cylindrical balloon technique.
Here a floating balloon catheter is used to cross the mitral valve and two guidewires are
positioned in the left ventricular apex. Al Zaibag reported successful valvuloplasty in 7
of 9 patients with severe mitral stenosis [Al Zaibag M et al 1986], Although effective,
the double balloon technique is demanding and carries a risk of left ventricular
perforation. The Inoue balloon catheter has since been shown to be safer and easier to
use [Chen C et al 1990] and is now the most popular technique worldwide. The
transvenous or antegrade approach using transeptal puncture is the most widely used.
The transarterial or retrograde approach represents an alternative in rare cases where
transeptal puncture is contraindicated.
The most recent development in the field of mitral valvotomy has been the introduction
of metallic commissurotomy by Cribier in Paris using a device similar to the Tubb's
dilator used during surgical commissurotomy [Cribier A et al 1999]). Cribier's
preliminary experience suggests that the device is as effective as balloon
commissurotomy. However, the method is more technically demanding and the risk of
haemopericardium seems higher because of the device and the presence of a guide wire
in the left ventricle. An important advantage of metallic commissurotomy is that the
dilator is reusable and therefore of particular value in developing countries where low
financial means limit the use of the Inoue balloon.
The efficacy of BMV has been confirmed in trials involving several thousand patients
[Cheng CR 1995][Iung B 1996], The technique is now well established as the treatment
of choice for rheumatic mitral stenosis in young patients with pliant, non-calcified
valves [Dean LS et al 1994][ Palacios IF 1995][ Chen C et al 1995]. In suitable patients
BMV can be expected to provide over 100% increase in valve area, with a final valve
2 .
area of 2 cm on average. The improvement in valve function results in an immediate
decrease in left atrial and pulmonary pressures, both at rest and on exercise. Studies of
longer term outcome up to 10 years are beginning to creep into the literature and one
large series confirms the late efficacy ofBMV [lung B et al in 1999].
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With the disappearance of rheumatic fever in the developed world, patients with mitral
stenosis presenting to Western centres today are elderly with valves less suitable for
BMV but higher operative risk. BMV would have a role in this group of patients if it
offered symptomatic improvement sustained for a reasonable period at low procedural
risk. The reported experience ofBMV in the elderly and those with marked degenerative
valve disease is limited and results have been largely unpredictable. Additionally, no
randomised studies are available for these patients and a comparison of the results of
PMC with those of surgical series is difficult because of the differences in the patients
involved. In Edinburgh I have the opportunity to study the benefits of BMV in a large,
heterogeneous elderly population. 300 patients were followed up for 1 to 10 years,
representing the largest reported long term follow up study in this age group.
1.4 Echocardiographic assessment ofmitral stenosis
-Historical development
The first clinical application of cardiac ultrasound was the diagnosis ofmitral stenosis.
In 1956, Edler and colleagues first documented the distinctive pattern of reflected echos
in mitral stenosis. They observed that on the M-mode echocardiogram the normal
anterior mitral leaflet closed partially shortly after initial opening to produce an early
diastolic "E-F" slope which was steep. In mitral stenosis, this early diastolic closure did
not occur or occurred at a much slower rate thereby diminishing the E-F slope (Figure2).
This reflected the slower filling of the left ventricle and tendency for the mitral valve to
be held open in diastole due to the persistent pressure gradient between the left atrium
and left ventricle. In 20 cases selected for commissurotomy, Elder demonstrated that the
degree of mitral stenosis found at operation corresponded to the reduced E-F slope and
the increased amplitude of movement of the anterior mitral leaflet after valvotomy
corresponded to dilatation of the mitral valve. The E-F slope was initially used to
quantify the severity of stenosis. However, investigators later found the correlation
between E-F slope and the degree of stenosis to be poor and this measurement is no
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longer used [Nichol P 1977]. Other M-mode characteristics of mitral stenosis include
abnormal anterior motion of the posterior mitral leaflet with reduced leaflet separation.
This probably reflects commissural fusion such that the leaflets act as a single unit. The
M-mode also produces dense lines with multiple echo reflections indicating thickened
and calcified leaflets.
Figure 2. M-Mode of the mitral valve
A. M Mode scan of a normal mitral valve showing motion of anterior (Ant) and
posterior (Post) leaflets and steep E-F slope.
B. M Mode scan in mitral stenosis showing thickened leaflets and reduced E-F slope
A B
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In the mid-1970s two dimensional sector scanning allowed real time tomographic
images of cardiac structures [Tajik A 1978] and provided additional qualitative
information in patients with mitral stenosis. The principle diagnostic feature on 2-D echo
is doming of the anterior leaflet in diastole. The leaflets may appear thickened and
calcified and this may extend into the subvalvular apparatus. The posterior leaflet is
relatively immobile and the left atrium is dilated. In the short axis parasternal view, the
narrowed orifice appears as a "fish-mouth" and commissural fusion and calcification can
be assessed.
The development ofDoppler echocardiography paralleled that of M-mode and 2-D echo
from the early 1950s, however it was not used clinically until the late 1970s. Doppler
echo provided for the first time a non-invasive technique for acquiring haemodynamic
data for the quantification ofmitral stenosis severity. Utilisation of the Doppler principle
also led to the development of colour flow mapping in the early 1980s allowing
visualisation of abnormal blood flow and semi-quantitative assessment ofmitral reflux.
Transoesophageal echocardiography (TOE) is a newer, semi-invasive imaging modality
which is now widely practised. The oesophageal window posterior to the heart provides
superior resolution of the mitral valve compared with transthoracic imaging. TOE also
allows clear visualisation of the left atrium and its appendage, which are not readily seen
from precordial images. TOE therefore has an important role in the detection of left
atrial thrombus in patients with mitral stenosis
Three-dimensional echocardiography (3-DE) is an exciting development in ultrasound
technology. The concept of 3-D ultrasound was first described by Baum and Greenwood
in the early 1960s [Baum G et al 1961], After obtaining serial parallel ultrasound images
of the human orbit, they created a 3-D display by stacking sequential photographic
plates bearing the ultrasound images. Since this pioneering work, recent advances in
computer technology, digital storage, manipulation and display techniques have meant
that 3-DE is now a practical reality. Images can be acquired and reconstructed rapidly
and 'real time' transthoracic 3-D probes are already commercially available. The study
ofmitral valve disease, in particular defining the site and extent of mitral valve prolapse
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and assessment of results of balloon mitral valvotomy, has become one of the most
promising clinical applications of 3-DE.
1.6 Echocardiography in patients undergoing balloon mitral valvotomy
In the 1950s during the era of surgical valvotomy, only physical signs and fluoroscopy
were available to predict valve anatomy. Balloon mitral valvotomy was introduced at a
time when echocardiography was available to examine the valve in more detail. Valve
morphology has been shown to be the strongest determinant of outcome after valvotomy
and 2-D transthoracic echo has become the cornerstone of assessment of patients
undergoing BMV.
A number of echo scoring systems have been devised which allow classification of
patients into anatomic groups with a view to predicting results. Most authors use the
Wilkins Score developed at the Massachusetts General Hospital [Wilkins G et al 1988]
(Table 1). Wilkins assessed four aspects of valve anatomy: leaflet thickening, leaflet
mobility, leaflet calcification and subvalvular thickening (figure3). Each is graded on a
scale of 0 to 4. Higher Wilkins Scores (>8) indicate more severe degenerative disease
and studies have shown this to be associated with lower success rates from BMV and an
increased risk of complications [Wilkins G et al 1988][Abascal V et al 1989]. Other
investigators like Cormier from Paris use a more general assessment of valve
morphology (Table 2).
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1 Highly mobile, only Minimal thickening Leaflets near normal Single area of
leaflet tips restricted just below leaflets thickness (4-5 mm) echo brightness
2 Leaflet mid and base Thickening of Mid-leaflets normal, Scattered areas
move normally chordae extending to considerable of brightness
one third chordal thickening of leaflet confined to
length margins (5-8mm) leaflet margins
3 Valve moves forward Thickening extends Thickening extends Brightness
in diastole mainly to distal third of through entire leaflet extends to mid
from base chords (5-8 mm) portion of
leaflets
4 No/minimal forward Extensive thickening Considerable Extensive
movement of leaflets and shortening of all thickening of all brightness
in diastole chordal structures leaflet tissue (>8-10 throughout much
extending to mm) of leaflet tissue
papillary muscles
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Table 2 Cormier's Score. Tinon and Bichat hospitals, Paris
Echocardiographic group Mitral valve anatomy
Group 1 Pliable, non-calcified anterior leaflet, mild
subvalvar disease (chordae >10mm long)
Group 2 Pliable, non-calcified anterior leaflet,
severe subvalvar disease (chordae <10 mm
long)
Group 3 Calcification of mitral valve of any extent,
as assessed by fluoroscopy, whatever the
subvalvar apparatus
Figure 3. 2-D Echo illustrating Wilkins Score
A. Mitral stenosis with low Wilkins Score ('good' valve for balloon valvotomy).
Leaflets slightly thickened at the tips, mobile anterior leaflet bows in diastole, no
subvalvular thickening, no calcification.
B. Mitral stenosis with high Wilkins Score ('bad' valve for balloon valvotomy). Leaflets
are thickened, rigid, heavily calcified with marked subvalvular thickening.
A B
The work of Kaplan and colleagues using excised human valves, demonstrated the
mechanism of balloon dilatation in mitral stenosis to be due to commissural splitting
[Kaplan J et al 1987], They also observed splitting through calcified commissures and
suggested that BMV would be efficacious in a wide spectrum of valves including those
with heavy calcification. Subsequent clinical studies using transthoracic
echocardiography [Fatkin D et al 1993][Cannan C et al 1997] have similarly shown that
increase in valve area is achieved by commissural splitting. More importantly, however,
calcified commissures resist splitting and strongly predict an adverse immediate and
long term result. Assessment of mitral commissural morphology, a feature not included
in the Wilkins Score, might improve patient selection for BMV. This is particularly
relevant in elderly patients now presenting to Western centres with severe degenerative
stenosis, in whom the outcome of BMV has remained largely unpredictable. In a series
of 400 patients I report the incidence of commissural calcification, the role of
transthoracic echocardiography in its detection and the importance of commissural
calcium on outcome after BMV
TOE allows superior resolution of the mitral valve and might offer a further advantage
in commissural assessment. This role of TOE has not been previously studied. In a
prospective study I have examined the value of TOE in the assessment of commissural
fusion and calcification and describe a novel 'Commissure Score' to reflect the
likelihood of commissural splitting. I have determined the accuracy of this technique in
predicting immediate outcome after BMV.
1.7 Measurement of mitral valve area
Limitations of current techniques.
Echocardiography remains the most widely used technique for quantification of mitral
stenosis. 2-DE allows direct visualisation of the mitral valve leaflet tips in the short-axis
parasternal view where the valve area can be measured by planimetry. However, 2-DE
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has the major limitation of visualising the valve in only one image plane which may not
be the plane of the orifice (figure 4). Incorrect alignment of the imaging plane
characteristically overestimates orifice size [Henry WL et al 1975], Since the image plane
is affected by patient positioning, transducer position and angulation, measurements are
subjective and prone to interobserver variability. The results are also dependent on image
quality. Rheumatic mitral stenosis is commonly associated with leaflet thickening and
calcification and therefore it may be difficult to accurately define the margins of the
mitral orifice. Moreover, anterior leaflet calcification causes acoustic shadowing which
obscures the mitral orifice. TOE provides improved resolution of the mitral valve and
overcomes problems of acoustic shadowing but the same image plane limitations apply to
the transgastric short axis view of the valve.
Figure 4. Limitations of 2-D Echo for planimetry of mitral valve area
Malalignment of 2-D short-axis image plane cutting through tip of posterior (A) and
anterior (B) mitral leaflets. The complete limiting orifice has not been defined.
Doppler echocardiography has been developed as an additional non-invasive technique
for quantifying mitral stenosis. The method of Doppler pressure half-time (PHT) was
described in 1979 by Hatle and provides a quantitative index of the rate of decay of the
diastolic transvalvular pressure gradient from which the valve area can be derived [Hatle
L et al 1979], Doppler tracings are generally easier to obtain and subject to less inter-
and intra- observer variability than planimetry. However, difficulty can arise when the
diastolic deceleration slope is non linear; mid diastolic flow must be analysed and
extrapolated to obtain the initial maximum velocity [Gonzalez M et al 1987]. In patients
with sinus rhythm and rapid heart rates the A wave is frequently superimposed on the
diastolic slope making measurement of E wave deceleration difficult or impossible
(Figure 5). Conversely, in atrial fibrillation, which occurs frequently in mitral stenosis,
there can be significant beat to beat variability in PHT measurements [Smith M et al
1991], PHT measurement is unreliable in the presence of significant coexisting mitral or
aortic reflux [Flachskampf FA et al 1990] [Wiesenbaugh T et al 1991], both of which
are common in rheumatic valve disease. The PHT method is affected by changes in
loading conditions and left atrial and left ventricular compliance. Measurements may
therefore be inaccurate in coexisting hypertension or immediately after BMV when there
are rapid changes in left atrial pressure and left ventricular filling [Thomas JD et al
1988],
Figure 5. Limitations of Doppler Pressure Half-Time
Measurement of pressure-half time is straightforward in (A) but difficult in the presence
of sinus tachycardia (B) and when E wave deceleration is non-linear (C).
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In selected cases where the severity of stenosis cannot be clarified by echocardiography,
for reasons detailed above, catheter derived mitral valve area based on the Gorlin
formula [Gorlin R et al 1951] is the widely accepted reference standard. However, this is
an invasive technique which is flow dependent and related to the functional rather than
the anatomic orifice. Measurements will vary with heart rate, rhythm, changes in LV
compliance and severity of mitral reflux [Cohen MV et al 1972], Left atrial size and
function as well as deformity of the mitral valve due to calcification and shortening of
the chordal apparatus may all distort flow patterns across the valve and contribute to
alterations in Gorlin derived MVA. Following BMV, the Gorlin area may be inaccurate
due to the development of significant mitral reflux or presence of an atrial septal defect.
Further errors are introduced when the pulmonary artery wedge pressure is used as an
indirect measurement of left atrial pressure, or if cardiac output is estimated rather than
directly measured [Nakatani S et al 1991].
1.9 Three-Dimensional Echocardiography for quantitative and qualitative
assessment of mitral stenosis
As yet there is no reliable 'gold standard' for the measurement of mitral valve area.
Three-dimensional echocardiography (3-DE) allows cardiac structures to be viewed
from any perspective and 2-D cut planes of any orientation can be selected from the 3-D
volume data, thereby overcoming the limitations of image plane positioning inherent in
conventional 2-D echo. This technique will allow planimetry of the mitral valve area in
the optimum plane of the orifice and could provide a 'gold standard' for quantification
ofmitral stenosis. I report the first in vitro study to validate the accuracy of 3-D TOE in
the measurement ofMVA.
I will also examine the expanding applications of 3-DE in the assessment ofmitral valve
morphology. From my own experience of this technology, I will describe the benefits





2.2 Data collection and analysis
2.3 Technique ofballoon mitral valvotomy
2.4 2-D Echocardiography for the assessment of patients undergoing BMV
2.5 3-D echocardiography
2.1 Patients
405 consecutive patients with mitral stenosis underwent BMV between 1986 and 1999
at the Western General Hospital, Edinburgh by a single operator (TRDS). Patients had
been referred from hospitals throughout Scotland, 20 were from England and 10 were
from abroad. Patients were selected for BMV if echocardiography showed their valve
anatomy to be suitable for improvement by commissurotomy or if, regardless of valve
morphology, they remained disabled on medical therapy but were high-risk candidates
for surgery. The baseline characteristics of these patients are discussed in chapter 3.
In 11 additional patients (2.7%), the procedure was attempted but not completed due to
failed transeptal puntcure (2), severe vasovagal reaction (1), balloon unable to cross
mitral orifice (5), Haemopericardium (2) and stroke due to dislodged thrombus (1). In
two severely ill patients, BMV was performed under general anaesthesia. In 4 cases,
BMV was combined with coronary angioplasty.
2.2 Data collection and analysis
Clinical, echocardiographic and invasive haemodynamic data for the 405 patients was
recorded before and immediately after BMV and documented in the patient records and
on a valvuloplasty database (FileMaker Pro). This information was analysed
retrospectively. In the 405 patients, values for mitral valve area and mitral regurgitation
grade were taken from the invasive catheter data. In concordance with other authors,
successful immediate outcome was defined as final MVA>1.5 cm2 without severe MR.
The Parsonnet Score [Parsonnet V 1989] was calculated for each patient. This risk
stratification method uses objective patient data to predict 30 day operative mortality
from open heart surgery.
Longer-term symptomatic follow up data was available for the first 300 patients.
Symptom status (New York Heart Association Class) after valvotomy was established
by clinic visit or telephone contact. Details of valve replacement and deaths were
obtained from general practitioners and referring physicians and Health Board mortality
records. Follow up of these 300 patients ranged from 1 to 10 years (mean 25 +/- 2.4
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years, median 2.0 years) and was 97% complete (8 patients lost to follow up). Successful
long term functional outcome was defined as being alive with sustained symptomatic
benefit of at least +1 NYHA class without having been referred for MVR or repeat
BMV.
Unless indicated otherwise, data are expressed as mean value +/- standard deviation.
Haemodynamic data pre- and post- BMV were compared using the paired Students t
test. Non parametric data and binary factors were assessed with respect to outcome using
the Mann-Whitney and Chi Squared test, respectively. Differences in the characteristics
of the 4 age groups were evaluated using ANOVA. Stepwise multiple linear regression
was used to analyse the importance of baseline variables as independent predictors of
immediate outcome. Long term symptomatic outcome was presented using the Kaplain
Meir method and predictors of long term outcome were determined using Cox
Regression analysis. A commercially available statistics package (SPSS version 9 for
Windows) was used for all calculations under the supervision of a professional
statistician (RE, University of Edinburgh)
2.3 Technique of balloon mitral valvotomy
Patients had been anticoagulated with warfarin for at least 3 months, this was
discontinued 3 days prior to admission. BMV was performed in the catheter laboratory
under local anaesthesia using fluoroscopic guidance. An 8 French Brockenborough
catheter was passed percutaneously from the right femoral vein to the right atrium and,
following transseptal puncture, into the left atrium (antegrade approach). A bolus of
heparin was administered intravenously.
The first 62 patients were treated by single or double cylindrical balloons based on the
methods described by Lock [Lock J et al 1985] and A1 Zaibag [A1 Zaibag M et al 1986]
and in the subsequent cases the Inoue balloon technique was used [Inoue K 1984],
Balloon size was chosen according to the patients' height. The Inoue technique utilizes a
catheter with a rubber-nylon balloon which is advanced across the mitral valve into the
left ventricle. Following inflation of the distal part of the balloon with contrast, the
balloon was pulled back to abut against the mitral orifice and then fully inflated (figure
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6). The balloon was progressively dilated to larger diameters. We found both the Inoue
and double cylindrical balloon techniques to have the same haemodynamic outcome
[Shaw TRD] but there was a shorter procedure time and fewer complications with the
Inoue technique.
Figure 6. Sequential inflation of the Inoue balloon in the left ventricle
Left ventriculography was performed following each inflation to assess the degree of
mitral regurgitation and further inflations were avoided if significant MR developed.
Mitral regurgitation assessed by ventriculography was graded from 0-4 using Sellers'
classification. Valve calcification was assessed by fluoroscopy and graded as (0) absent,
(1) mild, (2) moderate or (3) severe.
Coronary angiography and right and left heart haemodynamic measurements were
performed before and after BMV. Cardiac output was calculated by the Fick principal
using assumed oxygen uptake and the mean mitral gradient was determined by
planimetry from simultaneous left ventricular and left atrial pressure traces. Mitral valve
area before and after BMV was calculated using the Gorlin formula [Gorlin R et al
1951], Coronary angiography was also performed in all patients. Patients were
monitored overnight on the cardiac ward, femoral sheaths were removed at 4 hours and
they were discharged home the following day if there were no complications
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2.4 2-D Echocardiography for the assessment of patients undergoing BMV
2.41 Transthoracic echocardiography
Prior to BMV, all patients underwent comprehensive 2-D transthoracic
echocardiography study using Hewlett-Packard Sonos 2000, Acuson 128 XP/10 or ATL
HDI LAB 5000 ultrasound scanners. Two-dimensional, M-Mode, colour and spectral
Doppler modalities were utilised.
Measurement of mitral valve area:
Pulsed Doppler analysis of diastolic trans-mitral flow was performed with the sample
volume at the tips of the mitral leaflets in the apical four chamber view and initial mitral
valve area (MVA) was derived by the Doppler pressure half time (PHT) method taking
the mean value of five recordings. Mitral valve area was also determined by planimetry
of the mitral valve orifice in the parasternal short axis view. After BMV, mitral valve
area was measured by planimetry the following day or by Doppler PHT at 1 month
follow up.
Assessment of valve morphology:
The mitral valve leaflet and subvalvular morphology was assessed in the parasternal
long axis view and graded according to the Wilkins Score (Appendix 1).
For assessment of the commissures, the mitral valve was examined in the short axis
parasternal view. Although by strict terminology the mitral valve has only one
commissure between its two leaflets [Anderson RH 1992], I have followed the common
convention of considering that the mitral valve has two commissures: posteromedial and
anterolateral. The echo beam was scanned repeatedly through the mitral apparatus and
the anterolateral and posteromedial commissures of the mitral valve were individually
examined. Echocardiographic calcium was identified by high intensity echos.
Commissural calcification was said to be present if there was brighter echocardiographic
density in the commissures than in the adjacent aortic root. The extent of commissural
calcification was quantified by grading each half commissure with such echos as 1. The
Commissure Calcification Grade for the valve could therefore range from 0-4 (Figures 7
& 8).
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Figure 7 Grading system for commissural calcification.
Severe stenosis but no bright echos
across either commissure
Grade: 0+0+0+0=0
Bright echos extending across one half
ofposteromedial commissure
Grade: 1+0+0+0=1
Bright echos extending throughout
posteromedial commissure
Grade: 1+1+0+0=2
Bright echos across half of each
commissure
Grade: 1+0+0+1=2
Bright echos across all of




Figure 8 Illustrative examples of commissural calcification.
Upper panel: thickening and brightness at leaflet tips but no bright echoes extending
across either commissure; grade 0000 = 0. Middle panel: bright echoes extend across half
of posteromedial commissure; grade 1000= 1. Lower panel: postdilatation the
anterolateral commissure has opened well but the posteromedial commissure had bright
echoes throughout its length and had resisted splitting; grade 1100 = 2
2.6 Transoesophageal echocardiography
The latter 310 patients also underwent transoesophageal echocardiography. TOE was
performed immediately prior to BMV following a 4 hour fast using a commercially
available 7 MHz multiplane transoesophageal probe and an Acuson 128 XP/10
ultrasound scanner. The pharynx was anaesthetized with xylocaine spray and the
examination was performed under intravenous sedation with midazolam. The mitral
valve leaflets and subvalvular apparatus were examined at midoesophageal and
transgastric levels. The primary role of TOE was to exclude intracardiac thrombus and
this required careful imaging of the left atrium, its appendage and interatrial septum.
TOE assessment of commissural morphology
In a subset of 72 patients TOE was also used to examine the extent of commissural
fusion and localization of commissural calcification. The mitral valve commissures were
scanned systematically at midoesophageal level. The anterolateral commissure was
visualised in the transverse plane by advancing and retracting the probe such that the
length of the fused commissure could be scanned from the leaflet tips to the mitral valve
annulus. The posteromedial commissure was scanned in a similar manner in the
longitudinal plane by rotating the probe clockwise and anticlockwise (Figure 9).
Commissural calcification was identified by high intensity echos casting an acoustic
shadow (Figure 10). Each commissure was assigned a score to reflect the likelihood of
splitting. A score of 0 was given if there was no fusion, or if commissural calcification,
expected to resist splitting, was present. When non-calcified fusion was present, a score
of 1 was given if the fusion was estimated to extend no more than 5mm from the annulus
and a score of 2 given when such fusion extended >5mm from the annulus towards the
centre of the valve. Each valve therefore had an overall 'Commissure Score' ranging
from 0 to 4, a high score indicating extensively fused, non calcified commissures which
were therefore more likely to split, whereas a low score indicated either minimal fusion
or the presence of resistant commissural calcification (Table 3).
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Figure 9. Mitral valve anatomy viewed from the left atrium with orientation of the
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or calcification ofboth commissures
Or absent fusion of one commissure, calcification of the other
1
Partial fusion of one commissure, absent fusion or calcification of
the other
2
Extensive fusion of one commissure, absent fusion or calcification
of the other
or partial fusion of both commissures
3
Extensive fusion of one commissure, partial fusion of the other, no
commissural calcification
4 Extensive fusion of both commissures, no commissural calcification
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2.7 Technique of three-dimensional echocardiography
A three-dimensional data set is composed of anatomical information from multiple static
2-D cross-sectional images which can be obtained from either transthoracic or
transoesophageal windows. These images are acquired in a sequential manner along or
around an axis, or using reference views. More recently, real time acquisition has been
performed by rapidly scanning through a pyramidal volume. For reconstruction of the
mitral valve, transoesophageal echocardiography is the preferred approach since it offers
a stable transducer location from which high resolution images of the mitral valve can be
acquired thereby improving the quality of the 3-D display.
The multiplane TOE probe is rotated at 2 or 3 degree increments over 180 degrees and
90 or 60 sequential 2-D cross sections are digitised to form a conical data set [Salustri A
et al 1995]. Optimal temporal and spatial registration is achieved by ECG and
respiratory gating. Off-line processing involves the conversion from polar to cubic
Cartesian co-ordinates and interpolation ofmissing information between 2D slices. From
the resultant data set, novel 2-D cut planes in any orientation can be selected (anyplane
echo) and multiple parallel cross-sectional 2D slices can be generated in any desired
plane (paraplane echo). A volume rendered 3-D image of the mitral valve can be
reconstructed from any perspective. This allows a full appreciation of the complex
geometry and spacial relationships of the mitral valve. Threshold limits are used to
separate cardiac structures from blood pool and background. Brightness and shading
provide perception of depth. With the added dimension of time (four-dimensional
echocardiography) we are able to study in detail the motion of the valve during the
cardiac cycle.
2.7 Study limitations and sources for error
This study included only patients referred for consideration for mitral balloon valvotomy
and does not reflect the characteristics of all patients with mitral stenosis. Relatively fit
patients with markedly degenerate mitral valves may have been referred by their
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cardiologist direct for cardiac surgery. Other frail patients with severe mitral stenosis
who were sufficiently controlled on medical treatment may not have been referred to the
cardiac centre for consideration of balloon valvotomy.
Echocardiography evaluation of commissural calcification and Wilkins criteria by
multiple observers is subjective and exposed to variability. The inferior resolution
offered by earlier echo machines would have made assessment more difficult and on
occasions inaccurate. Bright echoes on the valves are taken to represent calcification but
may also be caused by dense fibrosis; a study of the correlation between echo
appearances and pathological findings would be required to confirm this assumption.
Immediate haemodynamic data was based on invasive measurements derived by the
Gorlin formula. Although this is generally regarded as the 'gold standard' and used by
most investigators, the Gorlin area is less reliable during changes of heart rate and
loading conditions which occur during valvuloplasty and further errors are introduced
when cardiac output is estimated (as in our own centre) rather than measured directly.
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CHAPTER THREE
Characteristics of 405 patients undergoing BMV
and comparison between four age groups.
3.1 Background
Reported series of BMV have been described mainly in young patients with pliable,
non-calcified valves. Since the disappearance of rheumatic fever in the Western World,
the characteristics ofpatients now presenting with symptomatic mitral stenosis to centres
such as ours has changed dramatically. The population is heterogeneous, patients tend to
be older and many have adverse valve morphology and significant comorbidity. There is
currently little data in the literature on the clinical and haemodynamic characteristics of
this population and this information is of interest to Western centres involved in the
selection ofpatients for BMV.
3.2 Aims
To evaluate clinical and haemodynamic characteristics of 405 patients undergoing BMV
at one high volume UK regional centre and to compare these within four age groups
(>40, 40-54,55-69,>70).
3.3 Patients and methods
See section 2.1. Four hundred and five consecutive patients with mitral stenosis
underwent BMV. Baseline clinical, echocardiographic and invasive haemodynamic data
were collected over a 13 year period. This data was documented in the patient records
and valvuloplasty database and I analysed these retrospectively.
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3.4 RESULTS
Table 4. Baseline characteristics of 405 patients
Age (years) 60.7 +/- 12.5
Female 79%
Atrial fibrillation 72%







Coexisting Aortic valve disease 17%
Coexisting mitral reflux 35%
LV impairment 11%
Coronary artery disease 22%
RV systolic pressure (mmHg) 52.8 +/- 19.4
Parsonnet Score 15.1+/- 8.6








Table 4 describes the baseline characteristics of the 405 patients undergoing BMV. Our
population was elderly with a mean age of 60.7, range 13 to 87. 112 patients (27.7%)
were aged 70 and above, 20 patients (4.9%) were octogenarians. The majority were
female and in atrial fibrillation. 22% had developed mitral restenosis following a
previously successful surgical or percutaneous valvotomy. These 405 patients had severe
symptomatic mitral stenosis with a mean pre- valve area of 0.93 +/- 0.3 cm and 73%
were in NHYA class III or IV. Medical and cardiac comorbidity was common. The
Parsonnet Score [Parsonnet V 1989] predicted the mean 30 day operative mortality from
mitral valve surgery at 15.1%. Twenty six percent of patients had been judged to be
unsuitable for surgery by either the referring physician or cardiac surgeon. The reason
for unsuitability for operation was additional severe inoperable, non-mitral disease in 8,
severe pulmonary disease in 33 and frailty and/or medical comorbidity in 67. The
commonest medical problems were renal failure, chronic neurological disability,
malignancy, severe arthritis, morbid obesity, diabetic complications and moderate
cardiac or pulmonary disease. Frequently several medical problems co-existed.
A significant number of patients had severe degenerative valve disease: one third had a
Wilkins Echo Score of 8 or more which would predict a poor outcome from BMV.
Moderate or severe fluoroscopic calcification was present in 23.7%. The latter 310
patients underwent transoesophageal echocardiography prior to BMV. Intracardiac
thrombus was detected in 41 cases (13.2%), all but one of these patients had been
anticoagulated with warfarin.
Baseline characteristics according to age groups
Of the 405 patients, 19 (4.7%) were aged <40, 101 (24.9%) aged 40-54, 173 (42.7%)
aged 55-69 and 112 (27.7%) were 70 years and above. Baselines clinical and
haemodynamic characteristics of these 4 age groups are shown in Table 5.
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Right ventricular and left atrial pressures were similar between age groups. Younger
patients had less severe mitral stenosis, although cardiac output was higher resulting in
an increased mean transmitral gradient compared with older patients.
Severity of stenosis increased with age and was paralleled by increased symptomatic
limitation (NYHA Class). Older age groups were less likely to remain in sinus rhythm,
were at increased risk of intracardiac thrombus and had greater comorbidity including
coronary artery disease. The Parsonnet risk scores in these elderly patients were
therefore higher and far fewer had been judged fit for mitral valve replacement.
Echocardiographic and radiological appearances showed that older patients also had
more severely deformed and calcified valves. Fluoroscopic valvular calcification was
moderate or severe in 43% of those over 70 compared with 22% of the under 70s. Of
those over 70 years, 55% had a Wilkins Score of 8 or more compared with 26% of those
under 70. Older patients were therefore less likely to have an optimal increase in MVA
from balloon dilatation.
3.5 Discussion:
Since the disappearance of rheumatic fever in the Western world, patients with mitral
stenosis presenting to centres such as our own are typically elderly. Other large
published series have generally included younger patients with mean ages ranging from
38 to 54 years [Chen C et al 1995][Iung B et al 1996][Dean L et al 1996], Our
population had a mean age of 60.7 years with 22% having developed restenosis after a
previous successful surgical valvotomy. These patients are on average 24 years older
than those who underwent surgical mitral valvotomy at our hospital when the operation
was introduced in the 1950s. In the 1930s it was found that of patients with mitral valve
disease 61% were aged under 40 [Wood P 1968] compared with 6% in our series.
A number of clinical features ofmitral stenosis have changed since Paul Wood reviewed
his experience of mitral valve disease in the early 1950s [Wood P 1954]. A history of
rheumatic fever is now less common than the 68% noted by Wood. In his series of 300
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patients, 83 had pregnancies associated with mitral stenosis compared with only one of
our 405 patients. He found an 18% incidence of severe haemoptysis while this was
reported in 2 (0.5%) of our patients. As most of our patients came from other cardiac
centres we did not have an accurate record of incidence of systemic embolism but it
appeared much lower than the 66% incidence in Wood's patients who had atrial
fibrillation. At operation 23% of his patients had left atrial thrombus which was much
higher than we found at transoesophageal echocardiography (warfarin was not available
at that time but was used by 95% of our patients).
I compared four age groups and illustrated the marked affect of age on the clinical and
haemodynamic characteristics of patients with severe mitral stenosis undergoing BMV.
Elderly patients undergoing BMV have more severe and symptomatically limiting
stenosis. A low cardiac output state in the elderly resulted in a lower mean transvalvular
gradient despite more severely narrowed valves; this should be taken into account when
assessing stenosis severity at cardiac catheterisation. Older patients have more severely
thickened and calcified valves indicated by the Echo Score and fluoroscopy. Also, as age
increases, atrial fibrillation is more common and there is a higher incidence of atrial
thrombus. BMV is therefore an unattractive option in these patients and mitral valve
surgery would normally be considered. However, this group would have an increased
mortality from mitral valve surgery predicted by the Parsonnet Score. This is the most
widely accepted system for estimating 30 day operative mortality from cardiac surgery
which assigns a 7% risk for patients aged 70-74, 12% for those aged 75-79 and 20% for
octogenarians. Surgical data confirm that mitral valve replacement is associated with
high morbidity and mortality in the elderly and carries a much higher risk than aortic
valve surgery. However, these series include predominantly patients with mitral
regurgitation secondary to papillary muscle dysfunction complicating ischaemic heart
disease where mortality is approximately 20% [Davis EA et al 1993], increasing to 50%
if combined with coronary artery bypass grafting [Tsai TP et al 1986], No large-scale
studies of mitral valve surgery for pure mitral stenosis are available. It is of interest that
59% of patients aged 70 and over were judged to be inoperable by the referring
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physician or cardiac surgeon due to comorbidity or frailty, compared with only 14% of
those under 70. BMV might therefore be the only available therapeutic option in many




Immediate outcome in 405 patients
and comparison between four age groups.
4.1 Background
Since its introduction in 1984, balloon mitral valvotomy has been used extensively and
its safety and immediate efficacy has been well documented [Chen C et al 1995][Iung B
et al 1996][NHLBI Registry 1992], Prospective randomised trials have shown that BMV
produces immediate haemodynamic, echocardiography and symptomatic results at least
as good as those obtained by surgical commissurotomy. [Farhat M et al 1990] [Reyes V
1994], However, these studies are described in young patients with pliable, non-calcified
valves. There is less experience of the safety and outcome ofBMV in older patients with
adverse valve anatomy and comorbidity and few studies have compared BMV in diverse
patient subsets. This information would be of value to Western centres dealing with a
predominantly older patient population and might improve case selection.
4.2 Aims
1. To assess the safety ofBMV in a heterogeneous population.
2. To analyse immediate haemodynamic and 3 month symptomatic outcome and to
compare these within the 4 age groups.
3. To identify predictors of immediate outcome.
4.3 Patients
(See section 2.1). 405 patients undergoing BMV at one high volume tertiary centre by a
single primary operator (TRDS). Clinical and haemodynamic data was analysed
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retrospectively from patient records and the valvuloplasty database. Baseline
characteristics have been described in chapter three
4.4 RESULTS
4.41 Complications
Of 416 patients in whom valvotomy was attempted (405 completed, 11 incomplete),
severe complications occurred in 17 patients (4.1%).
One patient died during the procedure (0.2%): she developed cardiac tamponade from
LV perforation by a cylindrical balloon. Two other patients developed tamponade but
underwent successful surgical repair. Two patients aged 65 and 69 died at 2 and 3 days
post-BMV; one from a severe stroke which developed during the valvotomy and one
from complications of lupus erythematosus and cerebrovascular disease. Embolic events
occurred in 7 patients (1.7%). Two had transient foot ischaemia, 3 developed evidence
of coronary embolism, 1 had transient diplopia and 1 had persistent hemiparesis. All
were over 60 years of age. Five patients developed severe mitral regurgitation requiring
valve replacement, although none required emergency surgery. Although many of the
elderly patients were unwell and sometimes moribund, they tolerated BMV well. No
other patients developed cardiogenic shock, acute pulmonary oedema, newly sustained
atrial or ventricular arrhythmia or required a vascular repair procedure.
A further 117 patients (29%) developed less severe complications. Most common of
these was left to right interatrial shunt. Significant shunting (Qp/Qs >1.5:1) was detected
by oximetry in 12 patients (3%). 24 patients (6%) developed moderate mitral
regurgitation. Other minor complications included transient arrhythmia, hypotension and
syncope. The development complications could not be predicted from any of the
baseline variables. Embolic events were confined to the older age groups (range 61-82
years). The number of patients alive and free from MVR was 97.3% at 3 months, falling
to 86.4% at one year.
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4.42 Immediate haemodynamic and symptomatic results
Table 6 Haemodynamic and symptomatic data pre- and post- BMV in 405 patients.
Before BMV After BMV P value
MVA (cm2) 0.93+/-0.3 1.7+/-0.7 <0.01
Transmitral gradient (mmHg) 12.6+/-5.2 5.7+/-2.9 <0.01
Cardiac output (1/min) 3.6+/-1.0 4.4+/-1.5 <0.01
NYHA class 2.97+/-0.73 1.9+/-1.0 <0.01
Mean LA pressure (mmHg) 25.0+/-7.0 20.4+/-7.3 <0.01
Data pre- and immediately post- BMV are shown in table 6. Immediately after BMV,
MVA and cardiac output increased, mean transvalvular and LA gradient was reduced
and NYHA class at 3 months was improved (all p<0.01). 58.8% obtained a final
MVA>1.5 cm2 without severe mitral regurgitation (successful haemodynamic outcome).
At 3 months, 80.7% of the 405 patients were improved by at least 1 NYHA class, 6
patients (1.5%) had undergone valve replacement and 5 (1.3%) had died.
The older groups also achieved a significant immediate haemodynamic improvement
although this was less pronounced compared with younger patients (table 7). There was
a trend toward a larger increase in valve area and cardiac output in the younger groups,
although this did not reach significant levels. Younger ages achieved a greater reduction
in mean transmitral and left atrial pressure gradients after BMV. Patients achieving a
successful haemodynamic outcome (MVA>1.5 without significant MR) included 79%
of those aged <40, 63% of those aged less than 70 and 48% of those over 70 (P<0.02).
The elderly were more severely symptomatically limited at baseline but all age groups
obtained a significant improvement in NHYA class at 3 months. Indeed, the degree of
symptomatic improvement indicated by increase in NYHA Class was greater in the






























































4.43 Predictors of outcome in 405 patients:
Variables predicting immediate haemodynamic success are listed in tables 8 (univariate
analysis) and 9 (multivariate analysis). Univariate analysis included 21 baseline patient
variables of which only 6 were not linked to immediate results: history of rheumatic
fever, previous valvotomy, presence of coexisting aortic valve disease, coronary artery
disease, LV impairment and balloon catheter type (double cylindrical vs Inoue). A
highly significant relation with poor outcome was seen with haemodynamic indicators of
severe stenosis (smaller pre-area, higher mean gradient and RV systolic pressure),
clinical variables (increased age, female sex, atrial fibrillation) and markers of severe
degenerative valve disease (X Ray calcification and higher Wilkins Score). Visualisation
of fluoroscopic calcification is a crude method for assessing valve morphology but
correlates well with outcome from BMV (Table 10).
Predictors of immediate haemodynamic success in 405 patients:
Table 8 Univariate analysis Table 9 Multivariate analysis
Baseline Variable t P value Baseline Variable P value Odds
Ratio
Pre-area 11.3 <0.001 Pre-area <0.001 1.79
Pre-cardiac output 8.7 <0.001 Female <0.01 0.85
XRAY calcium -6.4 <0.001
Echo Score -6.3 <0.001 Xray <0.02 0.94
Pre-RV systolic pressure -5.8 <0.001 Calcification
Parsonnet Score -4.7 <0.001
Operable 4.0 <0.001 AF <0.02 0.91





Pre-mean LA grad -3.0 <0.01
Pre-MR -2.2 <0.05
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Table 10. Influence of fluoroscopic calcification on immediate outcome of BMV.
Fluoroscopic Calcification Increase in MVA MVA >1.5 cmsq, no severe
Grade (cmsq) MR
0 0.9+/-0.61 70%
1 0.79+/-0.5 62 %
2 0.67+/-0.48 42 %
3 0.63+/-0.38 25 %
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Wilkins Score and Outcome
Figure 11 shows the correlation between Wilkins Score and increase in valve area
(r=-0.22, p<0.001). Although this was significant, there was substantial scatter in the
data; a third of those with a low score still had a poor result. Using the conventional cut¬
off of 8, a Wilkins score of 8 or less predicted a good outcome with a both sensitivity
and specificity of approximately 65%. Analysis of the four individual Wilkins factors
showed that all were significantly related to immediate outcome. Leaflet calcification
was the most powerful predictor and a stronger correlation was obtained when the four
factors were combined rather than used individually.




The forth and final multivariate logistic model included four variables (table 9). The
strongest independent predictor of immediate haemodynamic success was initial valve
area'. Males2 and those in sinus rhythm3 were more likely to have a successful outcome.
Mitral valve calcification identified by fluoroscopy4 predicted an adverse outcome.
The severity of stenosis progressed in parallel with degenerative disease of the leaflets
and subvalvular apparatus and therefore those with a smaller initial valve area had a
higher Wilkins Echo Score. When pre-catheter variables only are included in the




BMV was well tolerated, even in the frail elderly. The overall incidence of severe
complications was 4.1% and showed a tendency to increase with age. The mortality
from BMV was much lower than the 15% predicted mortality from cardiac surgery and
compares favourably with the reported proceduralmortality of 0-3%.
One of the most devastating complications of BMV is systemic embolism which is
reported to occur in 0.5-5% of cases. Embolism is likely to arise from left atrial
thrombus and often involves the cerebral circulation. Seven of our 405 patients (1.7%)
suffered systemic embolism during or within 48 hours of the procedure. All were over
60 years of age and this is reflected by the higher incidence of left atrial thrombus and
atrial fibrillation in this age group.
Cardiac perforation is a major cause of mortality in patients undergoing BMV and may
be a result of atrial puncture during transseptal catheterisation or from LV perforation by
guidewires. Haemopericardium occurs in 0.5-12% of cases in reported series. The single
death during BMV in this series was caused by LV perforation and occurred early in our
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experience when the double cylindrical balloon was used. The newer Inoue balloon
avoids guidewire manipulation in the LV and compared with single- or double-balloon
techniques, cardiac perforation with the Inoue technique is much less common (<2% vs
4%) [Bassand Jet al 1991],
The development of new or increased MR is a well recognised complication ofBMV. A
significant increase in MR was seen in 27 (6.5%) of our patients, although this was
severe in only 5 (1.2%). The creation of new or increased MR is reported to occur in as
many as 19 - 85% of patients and is severe in 3-10% [NHLBI Registry 1992][Essop M
et al 1991], Mild MR commonly occurs at the sites of commissural splitting. Severe MR
is usually due to non-commissural tearing of the mitral valve leaflets and less commonly
damage to the subvalvular apparatus. Although the need for urgent surgery (within
24 hours) is rare, it may be required for massive haemopericardium or severe mitral
regurgitation with haemodynamic collapse or refractory pulmonary oedema. In those
escaping emergency valve replacement, significant MR confers an adverse short-term
prognosis; 6 of the 27 patients (22%) in our series developing moderate or severe MR
either died or required a mitral valve replacement within 3 months, compared with only
1.3% of those without significant MR. However, I was unable to predict the
development of complications including MR from baseline anatomical, clinical or
haemodynamic variables. The NHLBI investigators showed overall complication rate to
be increased in those with smaller pre-MVA and higher Echo Score, but prediction of
MR remained elusive. Padial [Padial et al] investigated 566 patients undergoing BMV of
whom 37 (6.6%) developed severe angiographic MR. Again, standard baseline
characteristics including the Wilkins Score could not reliably predict MR. However,
they developed a novel score based on the combined echocardiographic assessment of
valvular thickening and calcification, degree and symmetry of commissural disease and
subvalvular disease which emerged as the only independent predictor of severe MR with
positive and negative predictive accuracy of 77% and 85% respectively.
The occurrence of an atrial septal defect during BMV is a well recognised feature of the
antegrade approach where transseptal puncture is required. The frequency of defects
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depends on the method used for detection. Transoesophageal echocardiography is the
most sensitive technique and detects shunting of various degrees in almost all patients
[Arora], these are generally small and undergo spontaneous closure. Oximetry detects
shunting in up to 20% of patients but these are significant (ratio > 1.5:1) in fewer than
5% (3% in our series). Even such large shunts improve, particularly in the presence of
maintained optimal valve enlargement and are rarely of clinical consequence [Cequier et
al 1990], They do, however, influence the invasive mitral valve area measurements and
account for discrepancies between results obtained haemodynamically and by
echocardiography [Manga P et al 1993]
4.52 Immediate outcome
Our results are in agreement with the literature, demonstrating the efficacy of BMV to
provide immediate functional and haemodynamic improvement. Catheter laboratory data
indicated a significant increase in mitral valve area and cardiac output and reductions in
transvalvular and left atrial pressure gradients. Mitral valve area increased by an average
of 117% from baseline. 58.8% of patients obtained a final MVA>1.5 cm2 without
significant mitral regurgitation. At 3 months, 80.7% were alive and symptomatically
improved. Greatest haemodynamic benefit was seen in the youngest patients: Those
aged under forty obtained an average increase in valve area of 152% to a mean final
valve area of approximately 2 cmsq and 79% achieved a valve area of > 1.5 without
MR. Older patients obtained a significant improvement in MVA (average increase
100%) and cardiac output despite their unfavourable valve morphology. However, this
increase in area tended to be less impressive than younger patients and their valves
tended to be more severely stenosed at baseline; consequently only 49% of the over 70s
achieved a final area of >1.5 cmsq. However, even a suboptimal haemodynamic result in
these severely limited patients resulted in useful symptomatic benefit indicated by
NYHA class. Indeed, symptomatic outcome at 3 months was not significantly different
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in the age groups with 82.6% of the under 70s and 80% of the over 70s achieving a
successful symptomatic result.
4.53 Prediction of immediate results
Prediction of immediate results was multifactorial, and based on both anatomic, clinical
and haemodynamic variables. In the 405 patients, multivariate analysis showed pre-
valve area, female sex, X-ray calcification and atrial fibrillation to be independent
predictors of immediate haemodynamic outcome.
Valve area before BMV was the strongest predictor. As we would expect, those with
more severe stenosis at baseline were less likely to achieve a final valve area of >1.5.
Other studies have also found smaller pre-MVA to be a highly significant predictor of
haemodynamic outcome and 30-day mortality [lung B et al 1996][NHLBI Registry
1992],
I found female sex to be a strong independent predictor of poor haemodynamic result;
55% of females had a successful outcome compared with 75% of males. Females were
of a similar age to males and had a similar Echo Score, however they generally
presented with more severe stenosis (p<0.01) and worse NYHA symptom class (p<0.01)
compared with males.
Atrial fibrillation was an independent predictor of adverse immediate outcome and was a
marker for adverse clinical and morphological features. Compared with those in sinus
rhythm, patients in AF tended to be significantly older (63.2+/-11.2 vs 54.2+/-13.3
years) with more severe stenosis (0.89+/-0.28 vs 1.01 +/- 0.33 cmsq) and lower cardiac
output (3.4+/-0.8 vs 4.3+/-1.0 1/min) - all p<0.001. Patients in AF had a higher incidence
of previous valvotomy (24% vs 29%, P<0.05). They also had more severe degenerative
valve disease indicated by fluoroscopic calcification score (089+/-1.14 vs 0.59+/-
1.0,p<0.02) and Wilkins Echo Score (7.0+/-3.0 vs 5.8+/-2.7, p<0.001). This concurs
with a recent study by Leon et al who showed that patients with AF have a worse short
and long-term prognosis from BMV [Leon et al 1999]
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Anatomic characteristics of the mitral valve were important predictors of immediate
results. Most studies of BMV have found valve morphology to be the strongest
independent predictor of outcome [Nishimura R et a 1990] [Palacios I et al
1995][Wilkins G et al 1988][Abascal V et al 1989][Tuzcu E], Visualisation of
calcification on X-Ray is a crude method of assessing mitral valve morphology which
does not discriminate between annular, leaflet and commissural disease. However, it is
relatively simple and objective and in our study fluoroscopic calcification grade was an
independent predictor of outcome.
The development of cardiac ultrasound has enabled us make a more detailed assessment
of mitral valve anatomy. Most centres performing BMV employ transthoracic
echocardiography scoring systems to guide patient selection, the most widely is the
Wilkins Score [Wilkins G et al 1988](Appendix 1). Patients with a score of </= 8 are
good candidates for BMV and have been shown to have better immediate and long-term
results. In a series of 130 patients, Abascal et al [Abascal V 1989] found that 84% of
those with a score of less than 8 had an optimal haemodynamic outcome (MVA >1.5
with 25% increase). However, in Abascals' series there was substantial scatter in the
correlation between Echo Score and increase in area and a significant proportion (43%)
of those with high echo scores of 8 or more also achieved an optimal result (Sensitivity
and specificity 72% and 73%, positive and negative predictive accuracy 84% and 58%
respectively). The Wilkins Score is subjective, prone to inter-observer variability and
many elderly patients with severely degenerate and calcified valves are poor echo
subjects. Our own analysis also showed only a modest correlation between Echo Score
and increase in area. Of the four Wilkins categories, leaflet calcification was most
strongly related to outcome. There was a moderate correlation between leaflet
calcification detected by echo and fluoroscopic calcification grade (r=0.69, p<0.01),
although only 47% of those with moderate / severe X-Ray calcification had a leaflet
calcification score of >2 on echo.
Data from surgical commissurotomy series indicate a restenosis rate of 11% at a mean
follow up of 6.5 years [Higgs] and 28% for a mean follow up of 11 years [Heger 1979].
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With the decrease in new cases of rheumatic fever in the West, the proportion of patients
presenting with recurrent mitral stenosis after surgical commissurotomy is increasing
and information regarding characteristics and outcome on this group of patients is of
value. Patients in our series presenting with restenosis are more likely to be female and
in AF, but other clinical and valvar characteristics were not significantly different. The
patients were of a similar age and valve degenerative change indicated by echo score,
commissure score and fluoroscopic calcification was not increased. This probably
reflects some selection bias. Anatomic studies have shown that mitral restenosis after
surgical commissurotomy may be associated with recurrent fusion of the commissures,
but also to rigidity of the leaflets and subvalvular apparatus without significant
commissural fusion. The latter cases are unlikely to improve by repeat commissurotomy
[Nakano S et al 1987] and such patients would have been referred directly to the cardiac
surgeons. In agreement with other published reports [lung B et al 1996], I showed that
patients with restenosis selected for BMV obtained a similar immediate haemodynamic
and symptomatic success rate without increased complications.
4.6 Conclusions:
In a heterogeneous population BMV was performed safely with low procedural
mortality and resulted in significant haemodynamic improvement. Immediate results can
be predicted from baseline clinical and anatomical variables. Male sex and sinus rhythm
predict better results. As with other authors, I found valve morphology to correlate
strongly with outcome. Fluoroscopic detection of the degree of calcification is a crude
method for assessing valve anatomy but emerged as a strong independent predictor: to
obtain >50% chance of a successful outcome, BMV should not be undertaken in those
patients with moderate or severe fluoroscopic calcification. Echocardiographic
assessment based on the Wilkins Score is most commonly used for the evaluation of
patients referred for BMV but had poor specificity and a modest correlation with
increase in valve area. Commissural morphology is not included in the Wilkins criteria
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but may be of value in refining the prediction of outcome. The importance of
commissural fusion and calcification will be explored in subsequent chapters.
Younger patients are more likely to have thin, pliant valves with little subvalvular
change and derive the best haemodynamic results from balloon dilatation. However,
there are now in the UK fewer such young patients with mitral stenosis. Of the patients
in our series, 29% who were aged less than 40, including the only teenager, had
immigrated to the UK from countries where rheumatic fever remains prevalent. The
population we now encounter is considerably older. Elderly patients tended to be less
suitable for BMV but are at significantly higher risk from cardiac surgery. Increase in
valve area was less than that achieved in younger patients with pliant, non-calcified
valves. However, the elderly obtained a similar degree of symptomatic improvement
measured by NYHA class at 3 months, even when the initial haemodynamic response
was suboptimal and complications of death or need for MVR were not increased. At
least in the short term, BMV appears to offer these elderly patients useful functional
improvement at low risk. Longer term follow up is required to evaluate whether this
initial symptomatic benefit seen in those with a suboptimal haemodynamic result is
sustained. This will be addressed in subsequent chapters.
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CHAPTER FIVE
Long-term outcome of balloon mitral valvotomy in 300 patients
5.1 Background:
To justify the use of BMV as an alternative to surgery for the definitive treatment of
mitral stenosis, the procedure should offer patients an acceptable period of symptomatic
improvement. I have shown that BMV offers immediate symptomatic benefit in the
elderly despite initial suboptimal haemodynamic results; longer-term data is required to
evaluate whether this is sustained over time.
Studies of longer term outcome of BMV are starting to appear in the literature. The
largest series of long term follow up was reported recently in a French series of 1024
patients, mean age 49 years followed up for a maximum 10 years, median 49 months
[lung B et al 1999], However, most other large series report only mid-term follow up
and there is limited data regarding the elderly, diverse patient subsets and patients with
suboptimal immediate results
5.2 Aims:
To study long term (maximum 10 year) symptomatic outcome of BMV in a large
heterogeneous population
To identify clinical and anatomical predictors of long term successful symptomatic
outcome.
5.3 Patients and Methods:
Longer-term symptomatic follow up data was available for the first 300 patients out of
the total 405 undergoing BMV by a single primary operator at the Western General
Hospital, Edinburgh. Baseline characteristics in the 300 patients are shown in Table 11.
Baseline characteristics for the 405 are similar and have been discussed in chapter 3.
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Follow up of the 300 patients ranged from 1 to 10 years (mean 2.4 +/- 2.3 years) and
was 97% complete (8 patients lost to follow up).




History of rheumatic fever 40%




Parsonnet Score 15+/- 8.8






Univariate and multivariate cox regression analysis of factors predicting long term
symptomatic outcome are shown at the end of the results text in tables 12 and 13
respectively. Kaplein Meir 10 year survival curves are also shown in Figures 12-17
where cumulative survival is defined as the proportion of patients alive, without MVR or
redo valvotomy who remain improved by at least +1 NYHA class.
At 1,3,5 and 7 years, survival without MVR/repeat BMV was achieved in 70%, 60%,
49% and 42% respectively. This criteria + sustained symptomatic improvement was
achieved in 61%, 52%, 42% and 33% respectively (Figure 12). Median survival without
MVR or repeat BMV and improved symptoms was 4.0 +/- 0.6 years.
In our 300 patients, multivariate analysis showed five variables to be independent
predictors of long term outcome after BMV: (1) post- valve area, (2) Parsonnet Score,
(3) Wilkins Echo Score, (4) LV impairment and (5) MR post-BMV.
The strongest independent predictor of long term symptomatic outcome from BMV was
initial haemodynamic success indicated by post- valve area. Fifty seven percent
achieved an immediate successful result (MVA>1.5, no severe MR). Of these patients,
12.5% either died or required MVR at 1 year compared with 29% of those with a
suboptimal initial result. Symptomatic success at five years was seen in 54% of those
with a successful immediate outcome compared with only 27% of those with initial
unsuccessful outcome (figure 13). Median +/- SE event free survival with symptomatic
improvement was 7.0 +/- 1.1 years vs only 1.0 +/- 0.48 years for those with a successful
and usuccessful immediate result, respectively.
The Parsonnet Score had an important affect on long term outcome (Figure 14). It was a
significant independent predictor in multivariate analysis and was the strongest
predictive factor in the over 70s age group.
Patients with more severe valvular degenerative disease indicated by the Wilkins Echo
Score had poorer long term outcome with early deterioration in symptoms. Sustained
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symptomatic improvement at 5 years was achieved in 49% of those with a baseline
Wilkins Score of <8. Of those patients with Wilkins Scores of >8, one third had either
died or been referred for MVR at a year and only 18.5% remained symptomatically
improved at 5 years (Figure 16).
The development of more than mild mitral regurgitation on cine ventriculography post-
dilatation resulted in an adverse long term outcome which appears striking on the
survival curves shown in figure 17. Seventeen patients (5.7%) developed moderate or
severe MR immediately after BMV. In most cases the MR was well tolerated at the time
of valvotomy. However, at one year follow up, 10 of these patients had required MVR
and another 4 had died (82% death or MVR). Of those without significant MR after
BMV, only 16% had either died or required MVR at one year.
When the Parsonnet Score is removed from the multivariate model, age, X-Ray
calcification and previous valvotomy emerge as independent predictors (Table 13). In
the over 70 age group, previous valvotomy and X-Ray calcification were the strongest
independent predictors of adverse outcome. Patients with a previous valvotomy had
similar age, valve area and valve calcification compared to the others but were more
likely to be female and in AF.
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Table 12. Long term symptomatic outcome in 300 patients: Univariate analysis of
predictors
Variable Score P value
Parsonnet Score 32.6 <0.0001
Post Area 25.8 <0.0001
X Ray Calcification 24.8 <0.0001
Wilkins Echo Score 24.1 <0.0001
Age 23.7 <0.0001
Operable 15 <0.001
Post Gradient 15 <0.001
Pre MR 14.3 <0.001
LV impairment 11.9 <0.001
NYHA class 11.9 <0.001
CAD 10.5 <0.001
MR post 9.5 <0.01
Previous BMV 6.3 <0.01
Post COP 6.3 <0.05
Pre COP 4.9 <0.05
Pre RV systolic Pressure 4.9 <0.05
AF 4.0 <0.05
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Table 13. Long-term symptomatic outcome in 300 patients:
Multivariate analysis of predictors with relative risks of adverse
outcome (no improvement in symptoms or death, redo BMV or MVR)
Parsonnet Score Excluded Relative risk P value
Post-Area (cm ) 0.36 <0.001
X Ray Calcification (0-3) 1.25 0.005
Age (years) 1.02 0.006
MR-Post BMV (0-3) 1.43 0.007
LV impairment (0-3) 1.61 0.021
Previous Valvotomy (Y/N) 1.44 0.040
Parsonnet Score included Relative risk P value
Post-Area (cm2) 0.35 <0.001
Parsonnet Score 1.04 <0.001
Echo Score (0-16) 1.09 0.002
LV Impairment (0-3) 1.79 0.005
Post-mitral regurgitation (0-3) 1.35 0.020
Figure 12 Long term success (survival without MVR or redo BMV and
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Figure 13. Long term success: relation with immediate haemodynamic result.
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I report long term (maximum 10 year) outcome from BMV in 300 patients, mean age
59.9 years. This is the largest series of long term follow up in such an elderly population.
Symptomatic success (alive, no MVR, +1 NYHA class) was achieved at 1,3 5 and 7
years by 61%, 52%, 42% and 33%. Poor functional outcome could be predicted by
baseline anatomical and clinical patient characteristics (Parsonnet Score, advanced age,
Echo Score, X-Ray calcification, LV impairment, MR, previous valvotomy). The
strongest independent predictor of long term outcome was the quality of the immediate
result, indicated by valve area post-BMV.
The largest study to date of long term outcome was conducted in France by lung et al.
They followed up 1024 patients for up to 10 years (median duration 4 years). Patients in
this and other studies of long term outcome from BMV were younger than our UK
series. In the study by lung, patients were on average 11 years younger (mean age 49
years), less likely to have AF (40% compared with 73%) and had less severe mitral
stenosis (mean MVA 1.1 compared with 0.91 cmsq). Direct comparisons with the results
of our study therefore cannot be reliably made but the general trends and predictors of
success are similar to our findings. Early experience from surgical commissurotomy has
confirmed that good immediate results from BMV lead to sustained symptomatic
improvement. Patients with a suboptimal increase in valve area or severe mitral
regurgitation usually have a poor prognosis and require surgery in the months following
BMV. lung et al found that 84% of patients with poor immediate results experienced >1
cardiovascular event and the majority underwent MVR, compared with only 19% of
those with good immediate results. Patients who did not undergo surgery generally had
contraindications to surgery, and most of them died of cardiovascular causes or became
rapidly symptomatic. lung and colleagues showed that if BMV is initially successful
survival rates are excellent, the need for subsequent surgery is infrequent, and functional
improvement occurs in the majority of cases. When functional deterioration occurs in
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these patients it is late and mainly related to mitral restenosis which affects 40% of
patients after seven years [Hernandez R et al 1999]
The preceding chapter indicated that older patients were less likely to obtain an optimal
immediate haemodynamic result from BMV. Despite this, significant symptomatic
improvement was seen at 3 months. However, I have shown that this is usually short¬
lived and such patients suffer rapid deterioration in functional state. Age has been
identified as a strong predictor of late results in series of surgical [Hickey MSJ 1991]
and balloon commissurotomy [Palacios IF 1995].
The Parsonnet Score was a significant independent predictor of long term outcome. This
scoring system includes an assessment of age, RV systolic pressure and comorbidity,
each of which has an important impact on outcome. Although this score is used widely
for risk stratification of patients undergoing cardiac surgery, it has not previously been
evaluated in patients undergoing BMV. The precise cause of deterioration was not
recorded in our study, many cases may have been due to associated comorbidity which
would be reflected in the Parsonnet Score.
Assessment of valve morphology was a useful method for predicting long term outcome.
Echo assessment based on the Wilkins Score was an independent predictor in all 300
patients and in the over 70s subgroup. With the Parsonnet Score excluded, X-Ray
calcification replaced the Wilkins Score as an independent predictor. Most reported
studies of mid and long term outcome after BMV have shown mitral valve anatomy
assessed by various echocardiographic scoring systems and fluoroscopy to have an
important impact on prognosis and a number have found this to be the strongest
independent predictor of outcome [Pavlides et al 1997][Meneveau N et al 1998][Abascal
V et al 1989][Cohen et al 1992], Meneveau followed up 532 patients and reported event
free survival at 7.5 years to be as high as 70% in those with favourable anatomy, falling
to 16% in those with the most severe degenerative change. In their study, valve anatomy
was scored according to the degree of subvalvular thickening and fluoroscopic
calcification. Cohen and Pavlides used the more widely accepted Wilkins Echo Score to
grade valve deformity and found this to be the strongest independent predictor of event
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free survival. A higher Echo Score has been associated with more rapid progression of
mitral stenosis in medically treated patients [Gordon S et al 1992], Moreover, mitral
valve calcification and immobility that are visible during the procedure, predict adverse
prognosis after surgical commissurotomy.
The development of moderate or severe mitral regurgitation on fluoroscopy post-BMV
conferred a dreadful prognosis. In our 300 patients, 5.7% developed grade 2 or 3 MR
after BMV. Although in most cases this was well tolerated immediately after the
procedure, within one year 82% of these had either died or undergone MVR. lung and
colleagues also found that a significant increase in MR resulted in adverse short and
long term outcome and early MVR should be considered in such patients. Mitral
regurgitation post-BMV could not be predicted from baseline factors (Chapter 4),
although those with more than mild MR prior to inflation were obviously likely to have
significant MR post-procedure and should be considered for MVR at the outset.
Previous surgical valvotomy predicted a worse long term outcome, despite these patients
achieving a similar result. At 1 year, 19 out of 69 (27.5%) of those with a previous
valvotomy had died or received a MVR, compared with 38 out of 222 (17%) of those
without a previous valvotomy (P<0.01). There was no difference in the age, or valve
morphology of the two groups, it is possible that previous valvotomy confers a more
rapid rate of restenosis. This differs to the findings of lung et al who showed that after a
good immediate result, over 50% of such patients remained improved at 8 years,
enabling reoperation to be deferred. However, this series included younger patients
selected on the basis of bilateral commissural fusion on echocardiography.
LV impairment also emerged as an independent predictor of long term outcome in our
series. Left ventricular end-diastolic pressure was a significant predictor on univariate
analysis and been shown to predict survival in studies of both BMV [Cohen D et al
1992] and mitral valve replacement [Salomon N et al 1977].
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5.6 Conclusions
Long term results of BMV in a diverse population can be predicted from baseline
variables. Selection of patients referred for BMV should include a careful assessment of
valve morphology, including the Wilkins echocardiographic Score and fluoroscopic
calcification. The Parsonnet Score is widely used for risk stratification of patients prior
to cardiac surgery, but has also been shown to be a useful and simple system for
predicting long term outcome after BMV.
Those achieving a final MVA >1.5 without mitral regurgitation are much more likely to
enjoy continued symptomatic benefit without the need for MVR. Where dilatation fails
to improve the valve area or creates significant MR, functional deterioration is often
rapid and chances of long term success are markedly reduced. The strong predictive
value of the quality of the immediate results stresses the importance of carefully
evaluating valve area and MR immediately after valvotomy. Valve replacement surgery
should be recommended early in those failing to gain satisfactory haemodynamic
improvement before further physical deterioration occurs in these elderly patients. For
patients in whom unfavourable valve morphology predicts a suboptimal haemodynamic
result, BMV can be expected to offer only short term palliation of symptoms. This is
often the case in very elderly patients, many of whom are at high risk from cardiac
surgery. No randomised study is available for older patients who have a less favourable
outcome and a comparison with surgical series is difficult because of the differences in
the patients involved and the fact that the surgical alternative can be not only
commissurotomy but also valve replacement. The role of BMV in older patients is still
debated and will be explored in the next 2 chapters.
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5.7 Limitations
Other long term follow up series have included mainly younger patients and the results
of these studies cannot be directly compared with our own. There was no randomised,
case-matched control group treated by surgical commissurotomy or mitral valve
replacement and it is unlikely that such studies will ever be conducted. Data on patients
who subsequently underwent MVR would have been useful but continued follow up in
this group was not performed. Echocardiographic follow up was not undertaken and
therefore symptomatic deterioration may not solely be due to progression ofmitral valve
disease. NYHA class as a measure of functional success is subjective but allowed rapid
assessment to be made from clinic notes and telephone contact.
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CHAPTER 6.
Long term outcome of balloon mitral valvotomy in patients aged 70
and over.
6.1 Background:
In Western countries patients now presenting with severe mitral stenosis are often of
advanced age as acute rheumatic fever has almost disappeared [Carrol et al 1993],
Analysis of their baseline characteristics (Chapter 3) has shown that these elderly
patients have more marked valvular and subvalvular calcification and thickening
unattractive for balloon dilatation. An optimal increase in valve area is less likely to be
achieved, predicting a poorer longer term symptomatic outcome. Such patients would
therefore normally require valve replacement. However, data from surgical series
indicate that elderly patients undergoing mitral valve replacement or repair experience a
higher mortality and morbidity and spend longer in hospital than younger patients [Nair
et al 1992][Fremes et al 1989]. Such patients may be content with a moderate
improvement in symptoms if this allows them to regain an independent although
restricted lifestyle. For this type of patient, therefore, percutaneous balloon valvotomy
might still represent a useful palliative treatment with lower procedural risk. As mitral
balloon valvotomy carries some risk to the patient and has an economic cost it would be
justified only if significant symptomatic improvement continued for a reasonable length
of time. I report our experience of mitral balloon valvotomy in patients aged 70 years
and over, who have been followed for one to 10 years. This study is unique in that I
compared outcomes in those patients judged unfit for surgery in whom BMV is the only
therapeutic option and therefore the decision to offer BMV is relatively straightforward,
and those patients judged to be fit for surgery in whom the role ofBMV as an alternative
to mitral valve replacement remains unclear.
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6.2 Aims:
1. To assess the immediate haemodynamic improvement and long term symptomatic
benefit ofBMV in 80 patients aged 70 and over
2. To compare baseline characteristics and results of BMV in patients judged suitable
and unsuitable for surgery
6.3 Patients and Methods:
Of 300 patients who had a mitral balloon valvotomy between 1986 and 1996, 80 (27%)
were aged 70 years or over. The mean age of these 80 patients was 75.2 + 4.2 years
(range 70-87:), 20 were octogenarians. There was a history of rheumatic fever or chorea
in 33 (41%). A previous surgical valvotomy had been carried out in 16 (20%) at a mean
of 25.3 + 7.5 years earlier (range 12-40). Patients had been referred from hospitals
throughout Scotland. All were UK-born. In an additional 4 patients balloon valvotomy
could not be completed, as described below.
In this age group the clinical status of the patients varied greatly. They ranged from the
fit elderly to those who were moribund. Fifty five (69%) of these 80 patients were
judged unsuitable for cardiac surgery by a cardiac surgeon or referring cardiologist. The
principal reason for unsuitability for surgical treatment was additional cardiac disease in
5 (severe left ventricular impairment and/or ungraftable coronary disease), pulmonary
disease in 12 and marked frailty in 8. Thirty patients had medical problems which singly
or in combination had resulted in the patient being considered unsuitable for surgery.
The medical problems were renal impairment, chronic neurological disability, co¬
existent cancer, severe arthritis, severe obesity, diabetes, pulmonary or cardiac disease
and moderate frailty. The mean number of additional medical problems in this group
was 3.0 (range 1-7). Twenty five of the 80 patients had been considered as acceptable
for surgery but had on echocardiography a mitral valve judged appropriate for treatment
by balloon commissurotomy. The characteristics of the patients in these two groups is
given in Table 14. Parsonnet Score, a prediction of mortality in the perioperative period,
was calculated for each patient
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Table 14
Characteristics of 80 patients aged 70 and over undergoing mitral balloon
valvotomy and judged as unsuitable or suitable for cardiac surgery.
Unsuitable for surgery Suitable for surgery
Patients 55 25
Female 47 (86%) 22 (88%)
Mean age (years) 75.9 ±4.4 73.6 ±3.0
Sinus rhythm 5 (9%) 4(16%)
Mitral reflux 27 (49%) 10(40%)
Aortic valve disease 16 (29%) 5 (20%)
LV impairment 12 (22%) 3 (12%)
Coronary artery disease 29 (53%) 5 (20%)
RV systolic pressure (range - mmHg) 62 ±24 47 ± 15
Symptom Class I 0 (0%) 0 (0%)
II 1 (2%) 4(16%)
III 26 (47%) 14 (56%)
IV 28(51%) 7 (28%)
Mitral valve calcification:
None 14 (25%) 12 (48%)
Mild 14 (25%) 6 (24%)
Moderate 7 (13%) 5 (20%)
Severe 20 (36%) 2 (8%)
Echo Score 8.3 ±3.2 7.4 ±2.7




Transthoracic echocardiography was carried out prior to balloon valvotomy as described
[section 2.4] and leaflet and subvalvar anatomy scored using Wilkins Echo Score
(Appendix 1). Echo scoring was by consensus of two observers and was done
prospectively in 59 patients and retrospectively from video recordings in the first 21
patients. The latter 53 (66%) patients also had a transoesophageal echo (TOE) study
immediately prior to the planned procedure to exclude left atrial thrombus. In 9 (17%) of
these patients left atrial thrombus was detected. The thrombus was within the auricular
appendage in 5 and was a smooth laminar wall thrombus in 2. These 7 patients
proceeded to same day mitral balloon valvotomy. In 2 patients thrombus protruding into
the left cavity was found and both had a further 3 month period of intensified
anticoagulation before undergoing balloon valvotomy. In 1 of these 2 patients the
thrombus had disappeared at repeat TOE and in the other it had regressed and appeared
organised. In 1 additional patient thrombus was situated at the interatrial septum; it
persisted after intensive anticoagulation and she was referred for surgery. All of the
patients found to have left atrial thrombus had been on warfarin therapy; 9 of the 10
were in atrial fibrillation.
6.32 Balloon mitral valvotomy
BMV was performed as previously described (section 2.3). In an additional 4 patients
aged over 70, completed balloon dilatation at the mitral valve was not achieved. In 3 of
the first 16 patients the cylindrical balloons then used could not be made to cross either
the atrial septum or the mitral orifice. In one patient hemiplegia developed before Inoue
balloon dilatation was complete.
6.33 Follow up
Symptom status (New York Heart Association (NYHA) Symptom Class) after
valvotomy was established by clinic visit or telephone contact. Details of valve
replacement and deaths were obtained from general practitioners and referring
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physicians and Health Board mortality records. Follow up was from 1 to 10 years
(mean+/-SE: 3.14 +/- 0.42 years) and was 100% complete.
6.4. RESULTS
Percutaneous mitral balloon dilatation was well tolerated, even in the critically ill
patients, and no patient died or developed a sustained major arrhythmia, pulmonary
oedema, or shock during the procedure or required a vascular repair procedure.
6.41 Haemodynamic change
The haemodynamic findings before and after balloon dilatation are given in Table 15.
Overall the mean transmitral gradient was reduced by 52%, cardiac output rose by 27%
and valve area increased by 89%. Post-dilatation valve areas greater than 1.50 sq cm and
1.20 sq cm were achieved in 40% and 67% of those unsuitable for surgery and in 60%
and 80% of those suitable for surgery. A successful haemodynamic result (MVA>1.5, no
MR) was achieved in 40% and 58% of those judged inoperable and operable
respectively, although this difference was not significant (p=NS). In the inoperable
group, patients with an Echo Score <8 were more likely to achieve haemodynamic
success (p<0.05), in those judged to be operable echo assessment of valve morphology
did not predict outcome. The increase in valve area in the 80 patients showed a
significant but weak correlation with Echo Score (r = -0.22, p <0.05)(Figure 18). Other
predictors of immediate outcome included pre-area, pre-cardiac output (both P<0.001)
and X Ray calcification grade (P<0.05). On multiple linear regression analysis only pre-
area and age were independent predictors of immediate success. Haemodynamic change
was similar in the four co-morbidity subgroups.
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Sixteen patients (20%) developed an increase in mitral reflux after dilatation. However
immediately after final dilatation reflux became mild in 11, moderate in 5 and severe in
none. No patient required emergency valve replacement. In 14 patients (18%) oxygen
saturation measurement detected a left to right shunt from atrial septal puncture of
greater than 1.2 to 1 (mean 1.50 + 0.39, range 1.2-2.7). One patient, treated by the
double cylindrical balloon method, developed marked atrial shunting (2.7:1) and later
required surgical repair of the atrial septum at the time of valve replacement. Three of
the 80 patients showed evidence of systemic embolism. One patient who did not have
TOE prior to balloon valvotomy, had a coronary embolus with subsequent mild LV
impairment. One patient, in whom TOE showed no left atrial thrombus, had transient
foot ischaemia. A patient with laminar thrombus at TOE had a transient diplopia. An
additional patient, in whom mitral balloon dilatation was not completed, had protuberant
left atrial thrombus which was erroneously thought to have become organised and
adherent at repeat TOE after intensive anticoagulant and developed a severe hemiplegia,
giving a total embolism rate of 5%. A small (1 cm) asymptomatic haemopericardium
was detected on post-valvotomy echocardiography in 1 patient. A total of 2 (2.5%) of
the patients therefore developed a severe persistent complication.
6.43 10 year symptomatic outcome
The Kaplan-Meier survival curves for patients suitable and unsuitable for surgery are
shown in Figure 19 and are compared to those of age and sex matched cohorts. In such
elderly patients one test of benefit is whether the patient is alive, has not undergone or
been referred for valve replacement and remains improved by at least 1 NYHA symptom
class. Figure 19 also shows the survival curves of those achieving this criterion.
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Figure 19
Survival and clinical status following BMV in patients suitable (left panel) or
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Of the 55 patients judged unsuitable for surgery this criterion was achieved at 1 year by
just over half - 28 (51%), at 3 years by 37%, at 5 years by 25% and at 7 years by 18%.
In these 55 patients initially judged unacceptable for surgery, 5 who did not improve
with balloon valvotomy and remained very severely disabled were subsequently
reconsidered by the cardiac surgeons and accepted for operation. However, operative
mortality was 40% and only 1 patient had an improvement in symptoms, confirming the
poor surgical outlook for this type of patient. In the 25 cases considered suitable for
surgery the criterion was reached at 1 year by 64% and at 3, 5 and 7 years by 45%, 36%
and 36% respectively. After balloon valvotomy 6 of these 25 patients had valve
replacement: operative mortality was 17% and all of the survivors obtained symptomatic
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benefit. Symptom class before balloon valvotomy and at 1-2 months, 1,3,5 and 7 years
after are given in Table 16. In both groups there was a progressive loss of symptomatic
benefit in survivors but improvement was maintained for several years.
Table 16 Symptom status of patients suitable and unsuitable for surgery before
balloon mitral valvotomy (BMV) and at various times afterwards
After BMV
NYHA symptom class Before BMV 1-2 months 1 year 3 years 5 years 7 years
Patients suitablefor surgery
I 0 20 28 19 22 20
II 16 52 28 19 0 0
III 56 24 16 12 11 20
IV 4 4 0 0 0 0
MVR - 0 12 19 22 20
Died - 0 16 31 45 40
(n) (25) (25) (25) (16) (9) (5)
Patients unsuitablefor surgery
I 0 15 15 9 3 0
II 2 49 33 21 16 10
III 49 25 9 14 16 16
IV 49 11 7 2 0 0
MVR - 0 5 0 0 0
Died - 0 31 54 65 74
(n) (55) (55) (55) (43) (31) (19)
Values are percentage or (number).
MVR, mitral valve replacement; NYHA, New York Heart Association.
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Predictors of 10 year symptomatic outcome (Cox Regression) for the whole group of 80
patients included Parsonnet Score, Wilkins Echo Score and LV impairment at baseline.
With the Parsonnet Score removed from the model, independent predictors of outcome
are LV impairment, RV systolic pressure at baseline and age. Considering only the
group of 25 patients judged operable, none of the baseline factors were predictive of
long term success in either univariate or multivariate analysis.
Subgroup of twenty octogenarians:
20 octogenarians underwent BMV and short term data were recorded. In 15 of the 20
patients MVA increased by more than 50% compared with baseline. Eight patients
obtained a final MVA>1.5 and 16 patients obtained a final MVA >1,2 cmsq.
One month following discharge, all patients were alive and none had undergone mitral
valve replacement. Improvement by at least 1 NYHA class was seen at 1 month in 15 of
the 20 patients with 12 patients in NYHA class I or II. There was no significant
correlation between baseline variables and success at one month.
Sixteen patients were followed up for 1 year: 8 of these were still alive of whom 7
remained improved by 1 NYHA class. Two patients had undergone mitral valve
replacement, one because of no symptomatic improvement and one for later development
ofmitral reflux: both died during surgery. An additional 3 patients died from congestive
cardiac failure, 2 from bronchopneumonia and one death occurred as the result of an
accident.
Favourable valve morphology was a powerful predictor of successful outcome at 1 year.
Of the seven patients alive and symptomatically improved, all had a Wilkins Echo Score




Percutaneous mitral balloon valvotomy was well tolerated in this group of elderly, often
frail and sometimes very ill patients and produced haemodynamic improvement. The
low rate of complications was similar to that found in younger patients [Dean,
Circulation 1994] although the final mitral valve area was smaller than in young patients
with pliable valves. The procedure would be justified however only if it appeared to
offer a better outcome than continued medical therapy or surgical treatment.
In 94% of the patients there was very severe symptomatic limitation (NYHA III and IV)
despite intensive medical treatment. In these patients medical therapy had been
maintained longer than would be usual for younger, more active patients. Continued
medical treatment was not an effective option for these patients: some were bed-bound
and for many others their cardiac symptoms threatened their independent lifestyle.
Mitral valve replacement in the elderly has a much higher mortality and poorer outcome
than in younger patients. Nicolaou and Kinsley [Nicolaou 1984] reported a 23% 30 day
mortality in 35 patients aged over 70 undergoing mitral valve replacement. Post
operative complications occurred in 57% and mean hospital stay was 16 days. Nair
found a 27% peri-operative mortality in 26 patients aged over 70, compared to 12% in
younger patients: at 5 years after mitral valve replacement 54% of their elderly patients
had died [Nair et al 1992], Edmunds [Edmunds et al 1988] reported a 90-day mortality
of 29% in octogenarians undergoing valve replacement. In a large series of 504 patients
aged over 70 who had mitral valve replacement (35% with concomitant coronary bypass
grafts and 38% with an additional valve replacement) between 1976 and 1996 Grossi
[Grossi et al 1998] reported a hospital mortality of 17%: for mitral valve replacement
alone mortality was 13%. Even after surviving mitral valve replacement, patients aged
over 70 have about 50% mortality at 4-5 years after operation [Edmunds 1998] and the
majority remain symptomatic.
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Fifty five of our 80 elderly patients were considered to be unsuitable for surgical
treatment because of their frailty or additional medical problems. Their Parsonnet Score
predicted a peri-operative mortality of 27%. Many of these 55 patients had degenerative
changes at the mitral valve and there was a high mean Echo Score of 8.3: mitral balloon
dilatation had been undertaken even when the valve anatomy was unattractive for
commissurotomy. In these circumstances balloon valvotomy might still be a useful
palliative procedure for the inoperable patient if even a moderate improvement in
symptoms was achieved. In this group, 51% were alive and improved by at least one
symptom class at one year after the procedure. This benefit decreased with time but
lasted a reasonable period, given the age and medical condition of the patients. lung et
al[Iung, EHJ 1995] achieved a mitral valve area greater than 1.5 cm2 in 66% of their 75
patients aged over 70 undergoing mitral balloon valvotomy: 4 year survival was 59%.
Our 25 elderly patients who were suitable for surgery underwent balloon valvotomy
because their valve anatomy appeared favourable for commissurotomy or because of the
patients reluctance to undergo operation: only 6 of the 25 patients had an Echo Score
greater than 8. At 1 year after balloon valvotomy 64% remained improved by at least
one NYHA symptoms class, without valve replacement. Six of the 25 patients
subsequently had valve replacement with a peri-operative mortality of 17%. These
patients, with a mean age of 74, therefore fared moderately well after balloon valvotomy
but significant symptomatic improvement was not achieved in one third at one year. In
this group of patients, outcome could not be predicted from baseline anatomical or
clinical variables. Ideally echocardiography would select accurately those patients who
would obtain substantial haemodynamic and symptomatic improvement from balloon
dilatation. I found, as have others, that the Wilkins Echo Score was an imperfect
predictor of increase in valve area. There is clearly a need to improve case selection so
that in those patients suitable for surgery one could identify those who would achieve
adequate symptomatic improvement by balloon dilatation, while taking account of the
more restricted desired lifestyle of the elderly and their higher surgical risk. Evaluation
of commissural calcification has been shown to improve the prediction of outcome after
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BMV [Fatkin 1993][Cannan 1997] and could refine the case selection of elderly
patients. As yet the importance of commissural calcification on long term results in large
numbers of patients has not been reported, this will be a focus in subsequent chapters.
Left atrial thrombus was found in 10 of the 54 patients who had TOE immediately prior
to planned balloon valvotomy despite all being on Warfarin therapy. This was a higher
incidence than found in younger patients. Mitral balloon dilatation was safely
undertaken in those with appendicular or laminar thrombus but any thrombus protruding
into the left atrial cavity should be a contraindication to balloon valvotomy.
This study included only patients referred for consideration for mitral balloon valvotomy
and does not reflect the characteristics of all patients aged over 70 who have mitral
stenosis. Relatively fit patients with markedly degenerate mitral valves may have been
referred by their cardiologist direct for cardiac surgery. Other frail patients with severe
mitral stenosis who were sufficiently controlled on medical treatment may not have been
referred for balloon valvotomy.
Conclusions
Percutaneous balloon valvotomy can help to achieve symptomatic benefit and a return to
independence for many elderly patients with mitral stenosis. In severely symptomatic
patients unable to have cardiac surgery, percutaneous balloon valvotomy is virtually
always worth attempting if there is any commissural fusion. In elderly patients in whom
echocardiography demonstrates a valve unsuitable for BMV, only short term
improvement can be expected and mitral valve replacement would be the best choice for
those individuals acceptable to the surgeon. However, in patients who are judged to be
unfit for MVR or who decline surgery, BMV should be considered as a short-term
palliative treatment. I found elderly patients gained useful short term symptomatic
benefit from BMV, even after a poor result from dilatation. Although precise data on the
prognosis of severe mitral stenosis in older patients is lacking, short term symptomatic
improvement should be considered a beneficial outcome in such severely disabled
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individuals. Such elderly patients with severe symptomatic mitral stenosis should be
referred to a cardiac centre for assessment. In elderly patients who are acceptable for
operation the Echo Score gives an approximate prediction of balloon valvotomy
outcome but remains imperfect: transoesophageal assessment of commissure fusion and




The significance of commissural calcification on outcome of mitral
balloon valvotomy:
A transthoracic echocardiographic study
7.1 Background:
Both immediate and long term success ofBMV depend heavily on the underlying mitral
valve morphology and this is currently assessed using the Wilkins Echo Score. Although
this scoring system has been shown to correlate with outcome of valvotomy in large
groups of patients its value in the prospective selection of individual patients for the
procedure has been questioned due to the weakness and scatter of individual predictive
correlations, and their poor negative predictive accuracy. Our own analysis showed that
one third of patients with a low Wilkins Score failed to achieve a valve area of >1.5
without MR and tended to deteriorate rapidly after BMV. 78% of such patients were
judged operable and would have been better served by MVR. Additionally, a third of
those with a high Wilkins Score predicting an adverse outcome obtained a good initial
result from BMV. In the early study by Abascal et al, 43% of patients with a score of >8
had a good outcome. In our over 70s population, patients judged fit for surgery were
selected for BMV if echocardiography showed the valve anatomy to be suitable.
However, 40% of this group failed to obtain a final valve area >1.5 after BMV and
symptomatic benefit was sustained at 1, 3 and 5 years in only 64%, 45% and 36%
respectively. In the elderly, BMV potentially offers both a definitive and palliative
treatment option but echocardiographic assessment must be refined in order to improve
case selection.
In vivo and in vitro studies [Reid CL 1987][Kaplan JD 1987] have confirmed that the
mechanism underlying the increase in valve area associated with BMV involves the
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splitting of one or both fused mitral commissures in a manner similar to surgical
commissurotomy. Calcified commissures tended to resist splitting by the balloon.
Therefore, assessment of commissural morphology should intuitively be an integral part
of assessment of patients referred for BMV. The Wilkins Score, however, does not
include commissural assessment and this is a major limitation of the scoring system.
There have been only two reports, with relatively small patient numbers, of the
importance of commissural morphology on outcome of BMV. In 149 patients
investigated by Cannan et al [Cannan 1997], the mitral commissures were assessed in
the short axis parasternal view. Commissural calcification was associated with a lower
survival rate and a higher incidence of mitral valve replacement after BMV. Fatkin et al
[Fatkin 1993] studied 30 patients using a similar transthoracic approach and
demonstrated that an assessment of commissural disease prior to BMV is useful for the
prediction of commissural splitting and the final increase in valve area. Both showed
that evaluation of commissural calcification is more useful than the Wilkins score in
predicting immediate and mid-term outcome. I report the incidence and epidemiology of
echocardiographic commissural calcification in our large elderly population and study
its relationship with outcome.
7.2 Aims:
1. To evaluate the epidemiological characteristics of commissural calcification in
patients undergoing BMV
2. To investigate the significance of commissural calcification detected by transthoracic
echocardiography on immediate and long term outcome ofmitral balloon valvotomy.
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7.3 PATIENTS AND METHODS
Patients
405 consecutive patients (mean age 61 +/- 12 years) undergoing BMV were studied.
Invasive haemodynamic data was recorded immediately before and after BMV (Chapter
2) Long term symptomatic outcome was available for the first 300 patients, follow up
ranged from 1 to 10 years, mean 2.5 +/- 2.4 years, median 2.0 years. Baseline
characteristics of the patients have been described (Chapter 3, Table 4)
Echocardiographic assessment
The mitral valve leaflet and subvalvular degenerative change was scored on the
transthoracic parasternal long axis images as described by Wilkins (Appendix 1).
The mitral valve commissures were examined in the short axis parasternal view, noting
areas of calcification as evidenced by bright, confluent echos. The extent of commissural
calcification was quantified by grading each half commissure with such echoes as 1
(Section 2.4). The 'Commissure Calcification Grade' for the valve could range from 0 to
4. A Commissure Calcification Grade of 2 could correspond to calcification of one
commissure or to calcification of half of both commissures: infact, in 96% of cases with
a grade of 2, calcification was localised to one commissure. No patient had a
Commissure Calcification Grade of 4.
During the 10-year period, echocardiographic assessment was by consensus of two
doctors who each performed a transthoracic echocardiogram prior to the procedure in
the latter 320 patients and retrospective review by TRDS from blinded video recordings
in the first 85 patients.
7.4 RESULTS
Echo Findings
The mean Wilkins Echo Score was 6.6 +/- 2.9 (range 2-16). Ninety two patients (23%)
received a score of >8.
Commissural calcification was identified in 110 patients (27%), 14% had a Commissure
Calcification Grade of 2 or more.
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Factors associated with commissural calcification
Relationships between the degree of commissural calcification and clinical and
echocardiographic variables are shown in table 17. The degree of commissural
calcification correlated strongly with pre-area, increasing age, male gender, clinical
status (as assessed by NYHA class and Parsonnet Score), the presence of left ventricular
impairment or coronary artery disease, radiographic mitral calcification and Wilkins
Echo Score. Multivariate regression analysis demonstrated that pre-area, male sex and
Wilkins Score were independent predictors of commissural calcification.
Table 17 Relationship between baseline variables and commissural calcification
Commissure Calcification
Grade
0 1 2 3 P
Number of Patients 296 53 53 4
Age (years) 60 63 65 55 <0.01
Gender (M:F) 55:241 14:39 13:40 3:1 <0.05
Rheumatic Fever (%) 37 36 51 50 NS
Atrial fibrillation (%) 71 75 81 25 NS
Surgical Valvotomy (%) 22 19 23 25 NS
NYHA 2.9 3 3.4 2.7 <0.001
Parsonnet Score 14.6 16.3 16.8 17 <0.05
X-Ray Cal Score 0.59 0.91 1.81 2.25 <0.01
Aortic valve disease (%) 17 21 17 25 NS
LV Impairment (%) 9 13 17 25 <0.05
Pre-Area (sqcm) 0.97 0.85 0.75 0.72 <0.01
Coronary disease (%) 18 32 30 0 <0.05
Wilkins Echo Score 6 7.3 9.2 8.2 <0.001
Mitral regurgitation (%) 35 40 34 25 NS
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Echocardiographic prediction of immediate haemodynamic result
Both Wilkins Score and Commissure Calcium Grade correlated significantly with
immediate outcome from BMV (Table 18).
Table 18: Relationship between the mitral valve area before and after balloon
dilation and the Echo Score and Commissure Calcification Grade. Mean (+/- SE)
Echo Score




111 203 73 18
Valve area
before
dilatation (cm2) 1.10(± 0.03) 0.9(± 0.02) 0.79(± 0.03) 0.66(± 0.06) <0.0001
Valve area after
dilatation (cm2) 2.12(± 0.08) 1.68(± 0.05) 1.48(± 0.06) 1.17(± 0.11) <0.0001
Increase in









295 53 53 4
Pre-valve area
before
dilatation (cm2) 0.97(± 0.02)
0.85 (± 0.03) 0.75 (±0.03) 0.72(± .04) <0.001
Valve area after
• 9
dilatation (cm ) 1.82(± 0.04) 1.7 (±0.1) 1.40 (±0.06) 1.21 (±0.2) <0.001
Increase in
valve area (cm2) 0.85(± 0.03) 0.85 (± 0.08) 0.61 (±0.06) 0.49 (± 0.2) <0.05
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The different types of degenerative mitral valve change tended to develop together.
Increasing echo score, reflecting leaflet and subvalvar changes, was significantly
associated with increasing commissural calcification (table 19).










In patients with an Echo Score ^ 8 ('good valves'), those with a commissure
calcification grade of 2/3 achieved a significantly lower increase in valve area than those
with grade 0/1 (Table 20). There was no significant difference seen in those with an
Echo Score >8 ('Bad valves'). Therefore, in patients without marked degenerative
disease of the leaflets or subvalvular apparatus, the Commissure Calcification Grade is
of additional predictive value.
Table 20: Effect of commissure calcification on increase in mitral valve area in
patients with Echo Score ^ 8 and Echo Score > 8. Values are mean (SD).
Commissure calcification Increase in valve Final valve area
grade area (cm2) >1.50 cm2
Patients with echo scores ^ 8
0/1 0.90 (0.64) 67%
2/3 0.67 (0.47) 46%
(p<0.01) (p < 0.05)
Patients with echo scores > 8
0/1 0.69 (0.51) 43%
2/3 0.62 (0.45) 19%
(NS) (NS)
Predictors of immediate haemodynamic outcome
By univariate analysis, the following patient characteristics were predictive of a final
valve area >1.50 sq.cm without severe mitral reflux: younger age, lower commissural
calcification grade, lower Echo Score, less fluoroscopic calcification, lower Parsonnet
Score (all p<0.001), sinus rhythm, male sex, and absence of mitral reflux (all p<0.01).
Previous valvotomy, effective balloon dilation area/sq.m BSA, type of balloon, left
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ventricular impairment and coronary disease were not significantly related to this
outcome.
On multivariate analysis less fluoroscopic calcification, male sex, sinus rhythm, and
lower commissure calcification grade (p<0.01) were independent predictors of this
outcome.
Echo Score, Commissural calcification and symptomatic improvement
Table 21 shows the NYHA symptom class scores before mitral balloon valvotomy and
at follow up 1-3 months later. In patients with an echo score of ^ 8, those with
commissure calcification grade 0/1 had a significantly greater improvement in symptoms
than those with grade 2/3. No difference was seen in those with an echo score of > 8
Table 21. Symptom class before mitral balloon valvotomy and alive at 1-3 months













Patients with echo score ^ 8
0/1 200 2.9 (0.7) 1.6(0.8) 1.2 (0.7)
2/3 27 3.1 (0.6) 2.2 (0.8) 0.9 (0.8)
(NS) (p<0.01) (p < 0.05)
Patients with echo score > 8
0/1 48 3.4 (0.7) 2.2(1.0) 1.2(0.8)
2/3 19 3.4 (0.7) 2.2 (0.7) 1.2 (0.8)
(NS) (NS) (NS)
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Mitral reflux after final dilatation
An increase in mitral reflux by two or more grades occurred in 4.1% of patients with
commissure calcification grade 2/3 and in 2.8% of those with grade 0/1 (NS).
Predictors of long term symptomatic outcome
Multivariate (Cox Hazard Regression) analysis of factors affecting long term functional
outcome over 10 years revealed nine variables as independent predictors. In order of
significance and with relative risks (RR) of adverse outcome (death, failure of
symptomatic improvement, redo BMV or MVR), these were: Increase in MVA cm2
(RR=0.29), Parsonnet Score (RR=1.04), Pre-mean LA gradient mmHg (RR=0.95),
LVEDP mmHg (RR=1.07), Post-MR 0-3 (RR=1.46) post-cardiac output (RR=1.21),
Commissure Calcification Grade 0-3 (RR=1.29), LV impairment 0-3 (RR=1.68), Pre-
MR 0-3 (RR=1.42). The Wilkins Echo Score was not an independent predictor of
outcome.
The impact of Commissure Calcification Grade on long term symptomatic outcome is
impressive (figure 20a). Of those with a Commissure calcification grade of 0 or 1, 50%
are alive and improved without MVR at 5 years, only 12% of those with commissure
calcification grade 2 or 3 achieve this success. The median survival with symptomatic
improvement and no referral for MVR is 5 +/-0.88 years in those with a commissure
calcification grade of 0/1 compared with 0.5+/-0.32 years in those with more extensive
commissural calcification.
The most favourable long term outcome was seen in patients with the combined
characteristics of a 'good Wilkins Valve' (Wilkins Score ^ 8) and a splittable
commissure (Commissure calcification Grade 0/1): median survival with sustained
symptomatic improvement without MVR was 7.24 years and this criterion was reached
in 84%, 77%, 68% and 60% at 1,3,5 and 7 years respectively (Figure 20b)
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Figure 20a: relationship between commissural calcification grade and long
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Figure 20b. Combined Wilkins Score and commissure calcification grade:
Affect on long term outcome
Follow-up (years after BMV)
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7.5 Discussion
Percutaneous mitral balloon valvotomy has two roles: as an alternative to open or closed
surgical valvotomy in patients with a mitral valve judged suitable for commissurotomy,
and as a palliative procedure in patients requiring valve replacement but considered to be
very high risk surgical candidates. Our series contained many elderly patients and 30%
had been judged unsuitable for surgery, so there was a wide spectrum of mitral valve
degenerative change.
I confirmed the relationship between the Wilkins Echo Score and haemodynamic and
symptomatic status before and after mitral balloon valvotomy but the Echo Score was a
weak predictor of increase in valve area for individual cases. Commissural calcification
was common in this elderly population (27% of valves) and was more likely to occur
with increasing age, in males and in those with more severe leaflet and subvalvular
degenerative change indicated by a higher Wilkins Score. In those patients with an Echo
Score of 8 or less, who are generally held to be suitable for balloon valvotomy, I found
that commissural calcification had a significant influence on both the increase in mitral
valve area and in symptomatic improvement. If a less than 50% probability of achieving
a valve area greater than 1.50 sq.cm by balloon dilatation is taken to be a justification for
valve replacement, then commissure calcification occupying the equivalent of one of the
two mitral commissures would be an indication for valve replacement rather than
balloon valvotomy. In patients with a low Echo Score (<8) and little or no commissural
calcification, percutaneous balloon dilatation offers significant haemodynamic and
symptomatic improvement which is sustained in 56% to 5 years. BMV is therefore the
preferred option in this population when cardiac catheterisation facilities and transseptal
puncture skills are available in view of reduced patient discomfort, short convalescence
and equivalent outcome. Patients with a higher commissural calcification grade
deteriorate rapidly with only 12% remaining symptomatically improved at 5 years and
therefore MVR should be considered in those with acceptable surgical risk. Multivariate
analysis showed that echocardiographic grading of commissural calcification was more
useful than the more widely accepted Wilkins Echo Score. There has been only one
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other study evaluating the impact of commissural calcification on longer term prognosis
after BMV. Cannan et al [Cannan 1997] reported medium term follow up (mean 1.8
years, range 30 days to 8 years) in 149 patients undergoing BMV. Absence of
commissural calcification predicted improved survival at 36 months free from the
combined endpoint of death, repeat balloon valvotomy or need for MVR (86% vs 4%,
p<0.001). Actuarial event free survival rates were superior in those without commissural
calcification and Cox regression analysis showed commissural calcification to be the
only independent predictor, superior to the Wilkins Score.
Fatkin et al [Fatkin 1993] also found that commissural echo-calcification predicted
commissural splitting in their group of 30 patients. Cannan et al [Cannan 1997] found
that in their 149 patients, commissural calcium was the only factor significantly
affecting clinical outcome after mitral balloon valvotomy. In these smaller studies, the
extent of commissure calcification was not quantified. Hernandez et al [Hernandez R
1999] noted that commissural calcium, identified by echocardiography, had been present
in patients who developed severe mitral reflux at Inoue mitral balloon valvotomy. This
could occur if resistance to commissural splitting led to leaflet tear. I found that a
marked increase in mitral reflux was uncommon, although found slightly more
frequently in those with marked commissural calcification (4.1% versus 2.8%). If
balloon dilatation is undertaken in a patient with commissural calcification then smaller
initial balloon size and a cautious progressive increase in balloon diameter should be
used.
In patients with an Echo Score >8,1 was not able to show a separate significant effect of
commissural calcification on increase in valve area, although the same trend was
present. Although such mitral valves are not ideal for a commissurotomy, percutaneous
balloon dilatation may be justified if the patient is unsuitable for surgery because of
comorbidity. Even limited haemodynamic improvement may give sufficient
symptomatic relief to maintain an independent lifestyle [Bernard Y 1992],
Mitral valve calcification seen at fluoroscopy was also a predictor of outcome.
However, fluoroscopy cannot accurately localise the calcific change and calcification
can affect outcome either through leaflet rigidity or commissural resistance.
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Echocardiography is preferred to localise any mitral calcification to the annulus, the
body of the leaflets or the commissures. This is helpful when there is slight calcification
localised at the commissure or, with generalised calcification, when splitting of
commissures may give a useful palliative result.
It would be desirable to improve the echocardiographic predictability of outcome of
mitral balloon valvotomy. The Echo Score is semi-quantitative and subjective. In a
multi-centre registry study, the Echo Score did not show a significant link with outcome
[Herrmann HC, 1992] but Post et al[Post JR 1995] found that on review of 87 patients
initially judged to have an Echo Score 10, 18 were reclassified as having lower scores
when judged by single-centre observers.
In this study, commissural calcification grade was assessed at transthoracic
echocardiography and it was found that calcification equivalent to one commissure was
associated with a less than 50% probability of achieving a good haemodynamic
outcome. Transoesophageal examination of both commissural calcification and fusion
may lead to further improved prediction of outcome by balloon commissurotomy,
particularly in patients who are difficult to scan from the transthoracic approach.
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CHAPTER EIGHT
Assessment of mitral valve commissural fusion and calcification:
Transoesophageal echocardiograpliic study
8.1 Background
Commissural splitting is the dominant mechanism of mitral balloon valvotomy. Results
of our own study and those of others [Cannan C et al 1997][Fatkin D et al 1993] have
shown that the echocardiographic assessment of commissural calcification can improve
the prediction of immediate and longer term outcome after BMV, adding significantly to
the currently accepted Wilkins Score. These studies have used transthoracic echo.
However, elderly and obese patients are sometimes difficult transthoracic subjects.
Transoesophageal echocardiography (TOE) is now performed routinely in most centres
prior to BMV, primarily to exclude left atrial thrombus. In comparison with TTE, TOE
offers superior resolution of the mitral valve apparatus and overcomes problems caused
by anterior leaflet shadowing, thereby allowing more accurate localisation of mitral
calcification. We have developed a novel TOE method which provides a systematic scan
of the whole length of the mitral commissure.
8.2 Aims:
(1) to evaluate this new TOE technique in assessing mitral commissural fusion and
calcification,
(2) to devise a Commissure Score based on TOE assessment to reflect the likelihood of
commissural splitting.
(3) to determine the accuracy of this Commissure Score in predicting immediate
outcome after BMV
(4) to investigate the accuracy of TTE assessment of mitral commissural morphology
compared with TOE in a subset ofpatients.





The series consisted of 72 patients with symptomatic mitral stenosis undergoing BMV,
mean age of 61.3 years (range 38 - 89 years). The majority (83%) were female and 66%
were in atrial fibrillation. Fifteen patients (21%) had presented with restenosis after a
previous surgical valvotomy. In eight patients judged inoperable by the referring
physician or cardiac surgeon, BMV was performed as a palliative treatment.
8.32 Echocardiographic study
Transthoracic echocardiography.
Initial MVA was derived by the Doppler pressure half time method taking the mean
value of five recordings. TTE was repeated within 24 hours of BMV and at 1 month.
The severity of mitral regurgitation post-BMV was assessed by colour and continuous
wave Doppler ultrasound.
Final MVA was measured by either planimetry of the mitral valve orifice in the
parasternal short axis view within 24 hours post-BMV, or by Doppler pressure half time
at 1 month follow up. A good outcome was defined as final MVA >1.5 cm and an
increase in valve area of >25% of the baseline value in the absence of severe mitral
regurgitation (MR) on echocardiography.
TTE assessment of commissural morphology was performed in the parasternal short-
axis view, as described in section 2.4. Both anterolateral and posteromedial mitral
commissures were individually examined for areas of confluent bright echos, taken to
indicate calcification.
Transoesophageal echocardiography.
TOE was performed in all patients immediately prior to BMV. The mitral valve leaflets
and subvalvular apparatus were examined in detail at midoesophageal and transgastric
levels and mitral valve anatomy was scored according to the criteria of Wilkins et al
[Appendix 1], The mitral valve commissures were scanned systematically at
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midoesophageal level and scored as described in Methods Section 2.5. Briefly, each
commissure was assigned a score according to whether non-calcified fusion was absent
(0), partial (1) or extensive (2). Calcified commissures usually resist splitting and scored
0. Both commissures were combined giving an overall 'Commissure Score' for each
valve of 0-4. Higher scores reflecting more extensively fused, non calcified commissures
which were therefore more likely to split, whereas a low score indicated either minimal
fusion or the presence of resistant commissural calcification.
8.33 Interobserver variability of TOE assessment
The TOE images of 30 patients (60 commissures) were retrospectively reviewed by 2
independent observers blinded to the outcome of the procedure. There was good
agreement between observers in the scoring of each commissure (kappa 0.73 and 0.75
for anterolateral and posteromedial commissures, respectively). Observers agreed on the
presence or absence of commissural calcification in all but one commissure (98%
concordance, kappa 0.95)
8.34 Comparison between TOE and TTE assessment of commissural calcification
In a subset of 33 patients, transthoracic assessment of commissural morphology was
compared with TOE findings. Retrospective analysis of video recordings was performed
by consensus of two observers. In these elderly patients with degenerative valve disease,
optimal visualization of the commissures was not always possible and 6 of the 33
patients (18%) were excluded because of inadequate transthoracic image quality. The
majority of these patients had been scanned on earlier ultrasound machines without
harmonic imaging capability. The extent of commissural fusion is difficult to quantify
reliably by the transthoracic technique and therefore only commissural calcification was
evaluated. Rising TOE as the 'gold standard', in the remaining 27 patients TTE correctly
detected 11 out of 12 calcified commissures (sensitivity of 92%). TTE incorrectly
localised leaflet calcification to the commissure in 7 cases (specificity 83%).
Interobserver variation for identification of commissural calcification by TTE was 7%.
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8.4 Results
8.41 Outcome from BMV
The mean Wilkins Score was 6.6 (range 3 - 12); 17 patients (24%) had a Wilkins score
greater than 8 predicting an unfavourable outcome from BMV. Balloon dilatation of the
mitral valve was achieved in all patients and mean MVA assessed by echocardiography
increased from 1.1 +/- 0.28 cm2 to 1.8 +/- 0.46 cm2 (P< 0.01). Invasive haemodynamic
measurements based on the Gorlin formula showed MVA to increase from 0.98 +/- 0.29
cm2 to 1.74 +/- 0.54 cm2
Eight patients (11%) developed severe MR on colour / Doppler echocardiography post-
BMV. A good outcome (final MVA >1.5 cm2, >25% increase, no severe MR) was
achieved in 40 patients (56%). Patients were divided according to outcome into groups
A (good) and B (suboptimal).
8.42 Commissure score
There was a significant correlation between the commissure score and outcome
following BMV, higher scores predicting a more favourable result (Table 22, Figure 20).
Thirty-seven out of 55 patients with a commissure score of 2 or more obtained a good
outcome compared with only 3 patients out of 17 with a commissure score of 0 or 1
(positive and negative predictive accuracy 67% and 82% respectively, PO.01).
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Table 22 Relationship between Commissure Score and outcome.
Commissure n A (Good) B (Suboptimal) % obtaining good
Score n=40 n=32 outcome
0 1 0 1 0%
1 16 3 13 19%
2 18 10 8 56%
3 20 14 6 70%
4 17 13 4 76%
P<0.01 (chi squared)
Figure 20. Correlation between commissure score and the increase in mitral



















Twenty four patients (33.3%) had calcification localised to either the anterolateral or
posteromedial commissure by TOE. No patients had bi-commissural calcification.
Commissural calcification predicted a suboptimal result, being present in 18% of group
A compared with 53% of group B (P<0.01).
In agreement with results from our transthoracic study of commissural calcification, the
incidence of commissural calcium increased significantly with advancing age and also
with increasing Wilkins Score (Table 23).
Table 23: Correlation between baseline variables and commissural calcificatoion
Commissural calcium No commissural calcium P value
(n= 24) (n=48)
Age (years) 68 58 0.001 t
Male: Female 5:19 7:41 0.5 *
Wilkins Score 7.6 6.5 0.013 t





The Wilkins Score also gave a significant prediction of outcome: mean Wilkins Score
5.9 +/- 2.1 vs 7.4 +/- 2.0 in groups A and B respectively, p<0.01. Patients achieving a
greater increase in valve area tended to have lower Wilkins Scores, although there was
substantial scatter in the data (Figure 21). Using the conventional cut-off of 8, the
Wilkins Score was less helpful in predicting good outcome compared with the
Commissure Score (positive and negative accuracy of 60% and 59% respectively,
p=NS). There was no significant correlation between the Wilkins Score and Commissure
Score.




In a multivariate linear regression model which included age, sex, rhythm, Commissure
Score, Commissural calcification and Wilkins Score, Both the Commissure Score
(p=0.0004) and the Wilkins Score (p=0.005) were shown to be independent predictors of
outcome from BMV.
8.46 Combined assessment ofWilkins criteria and commissural morphology
A combined evaluation of the positive features of valve anatomy (splittable, non-
calcified commissural fusion) and negative features (commissural calcification,
degenerative change in the leaflets and subvalvar apparatus) helped to further refine the
prediction of outcome. In patients with 'good' Wilkins valves (Wilkins Score 8 or less),
leaflet and subvalvular change is minimal and severe stenosis is due predominantly to
commissural fusion. In such cases the Commissure Score (assessing non-calcified,
splittable commissural fusion) was more accurate in predicting outcome. In this group
of patients a Commissure Score of 2 or more predicted a good result with positive and
negative predictive value of 75% and 80% respectively. In those with 'bad' Wilkins
Valves, only 47% of those with a Commissure Score of 2 or more obtained a good
result.
8.47 Mitral regurgitation
I was unable to demonstrate a significant correlation between Commissure Score and
the development of severe echocardiographic MR. The eight patients developing severe
MR had a significantly higher Wilkins Score (8.4 +/- 1.9 vs 6.3 +/- 2.1, p<0.02). I
observed that 4 of the 8 patients who developed severe MR had commissural
calcification: in these 4 cases transthoracic echocardiography in the short axis
parasternal plane showed the mechanism of mitral regurgitation to be a leaflet tear
adjacent to the area of calcification.
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8.5 Discussion
Commissural calcification was identified in a third of our elderly population and
predicted an adverse immediate outcome. Although the Wilkins Score does not
specifically assess the commissures, there was a significant correlation between Wilkins
Score and commissural calcification. In agreement with the previous transthoracic study,
this suggests that degenerative disease of the commissures progresses in parallel with
leaflet and subvalvular disease. Heavy generalised leaflet calcification is likely to
involve the commissures. For these reasons, the Wilkins Score remains a useful
screening tool for patients referred for BMV and in our study was a significant
independent predictor of outcome. However, the results of the present study, and those
of Fatkin et al, Cannan et al and Sutaria et al, have shown that echo assessment of
commissural morphology has important additional predictive value. In our patients, the
Commissure Score was a more accurate predictor of outcome than the Wilkins Score.
Two-dimensional TTE remains the most commonly used technique for the assessment of
mitral valve morphology and provides a rapid and safe screening tool for the selection of
patients for BMV. In the present study, TTE was shown to have a high sensitivity
(92%) for detecting commissural calcium. However, in a significant proportion of
patients (18%), the commissures could not be adequately visualised. There was a
tendency to incorrectly localise leaflet calcium to within the commissure which reduced
the specificity (83%). TOE is performed routinely prior to BMV in many centres such as
our own. Transoesophageal imaging offers improved resolution and more accurate
localisation of calcification than TTE. A semiquantitative assessment of the extent of
non-calcified commissural fusion was also made using a previously unreported system.
Calcified commissures were shown to be strongly associated with adverse outcome. In
cases where one commissure was calcified, absent or minimal fusion of the opposite
commissure (commissure score 0 or 1) resulted in a good outcome in only 18%. In the
absence of commissural calcium, a low commissure score of 0 or 1 could also arise
when mitral stenosis is mild or when stenosis is caused by disease localised to the mitral
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leaflets and / or subvalvular apparatus rather than the commissures, a situation not
infrequent after a previous surgical valvotomy. In both cases, a satisfactory increase in
valve area is unlikely to be achieved by balloon dilatation. Evaluation of commissural
fusion as well as calcification should therefore provide a scoring system which more
accurately reflects valve splittability. Consistent with this hypothesis, I found a strong
correlation between Commissure Score and increase in valve area (Figure 20), p<0.001.
Transoesophageal echocardiography is a semi-invasive technique and therefore clear
benefits must be demonstrated in order to justify its routine use prior to BMV. A number
of studies have compared the relative merits of TTE and TOE in the assessment of
patients undergoing BMV. Left atrial thrombus cannot be reliably excluded by TTE due
to its inability to fully visualise the left atrial appendage in all patients [Cormier B
1991][Kronzon I 1990] [Thomas MR 1992] and TOE is now routinely performed in
many centres prior to BMV for this reason. The longitudinal transgastric plane, when
available, also allows more detailed visualisation of the chordae and papillary muscles
compared with TTE [Rittoo D 1993], TOE also has a role after BMV since it is more
accurate in determining the severity and mechanism of mitral regurgitation and in
evaluating the degree of any residual left to right shunting across the interatrial septum
[Cormier B 1991].
However, the specific value of TOE in the assessment of commissural morphology has
not been demonstrated previously. Other investigators have advocated the use of the
transgastric window to obtain an image corresponding to the short axis parasternal view
of the valve orifice. However, the mitral valve is conical in shape so the commissures do
not lie in a single plane and poor quality images are obtained when there is marked left
atrial dilatation. As a consequence, this technique has not been shown to provide
adequate visualisation of commissural calcification and fusion [Thomas MR 1992]
In the midoesophageal plane posterior to the left atrium, the mitral valve can scanned at
high frequency and is clearly visualised in all patients. We advocate systematic scanning
of the anterolateral and posteromedial commissures in the transverse and longitudinal
planes, respectively [Rittoo D 1993][Essop M 1991]. A further advantage of TOE over
TTE is that acoustic shadowing from leaflet calcification is cast behind the valve into the
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left ventricle and is less likely to obscure the orifice, thereby allowing more accurate
localisation of mitral calcification. The present study is the first to report the advantages
of TOE over conventional TTE for the assessment of commissural calcification and
fusion and to demonstrate the value of TOE in predicting procedural outcome following
BMV.
It remains that 33% of patients with a high Commissure Score (2 or 3) still failed to
achieve a good outcome. This reflects the strict criteria for success used in our study and
also suggests that outcome is influenced by multiple aspects ofmitral valve morphology.
A combined assessment of favourable anatomical features (non-calcified commissural
fusion) and unfavourable anatomical features (leaflet and subvalvular change,
commissural calcification) is likely to be the best approach for evaluating patients
referred for BMV. In accordance, the positive predictive value of the Commissure Score
was improved in those patients with 'good' Wilkins valves in whom commissural
fusion is the dominant cause of stenosis.
Significant mitral regurgitation is a relatively frequent complication of BMV but one
which remains difficult to predict from baseline anatomical and clinical variables
[Elernandez R 1992], A mild increase in MR frequently occurs following BMV at the
sites of successful commissural splitting [Fatkin D 1993][Rittoo D 1993][Hernandez R
1992], In 40 patients studied by Essop et al, the most common cause of severe MR
following BMV was shown to be non-commissural tearing of the mitral leaflets.
Surgical data from patients undergoing early mitral valve replacement for severe MR
following BMV have shown that the mechanism of severe MR usually involves a leaflet
tear associated with commissural calcification [Cormier B 1991. Hernandez et al noted
that as well as commissural calcification, severe subvalvular disease was often found at
surgery in patients with severe MR post BMV. This would be reflected in the Wilkins
Score which I found to correlate with severe MR. In the present study, commissural
morphology was not a significant predictor of severe MR, although half the patients
developing MR had commissural calcification.
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8.6 Conclusions
This is the first study to demonstrate the value of TOE in assessing mitral commissural
fusion and calcification in patients undergoing BMV. These factors form the basis of a
novel Commissure Score which is reproducible and a useful predictor of immediate
outcome after BMV. Application of this scoring system during routine TOE examination
prior to BMV could improve patient selection.
Patients with unfavourable commissural morphology (indicated by a Commissure Score
of 0 or 1) are less likely to obtain a good result from BMV and mitral valve replacement
would need to be considered. Exceptions to this rule might include elderly patients or
those with a prohibitively high surgical risk. In such cases, we recommend cautious
inflations using smaller size balloons when commissural calcification has been
identified, accepting a suboptimal reduction in gradient. Conversely, some elderly
patients who were previously regarded as unsuitable for BMV on the basis of their
severely degenerative valve disease and high Wilkins Scores, may obtain a good
outcome if commissural morphology is favourable.
118
CHAPTER NINE
Three-Dimensional Echocardiography in mitral valve disease
9.1 Background
Whilst conventional two-dimensional echocardiography is crucial to our understanding
of the complex anatomy and three-dimensional spacial relationships of cardiac
structures, it requires the mental integration of a limited number of 2-D imaging planes.
This mental 3-D reconstruction is inherently variable according to observer experience
and expertise, and can only be described to other clinicians (such as surgeons) rather
than displayed reproducibly. The display of cardiac anatomy in three dimensions from
any perspective would have clear advantages over conventional two-dimensional
imaging and provide an insight into the functional and anatomic properties of cardiac
structures. Recent advances in ultrasound and computer technology have been combined
such that dynamic three-dimensional echocardiographic imaging is now a practical
reality.
Three-dimensional echocardiography (3-DE) has been shown to be more accurate than
2-DE in the quantification of cardiac volumes [Sapin P 1993][Munoz R 2000], These
studies used either manually contoured, static "wire-frame" reconstructions or dynamic
"volumetric" automated reconstruction technology that is now commercially available -
I have concentrated on the latter methodology in this review. The benefits of 3-DE are
particularly well suited to the study of the mitral valve given its complex morphology
and the importance of delineating its anatomy precisely in various pathological states.
This was demonstrated by Levine [Levine R 1989] who used wire frame reconstruction
of the mitral valve to define the 3-D morphology of the mitral annulus and its
relationship to mitral leaflet position, thereby clarifying the echocardiographic definition
of mitral valve prolapse. The assessment of patients with mitral valve disease is one of
the most promising clinical applications of this technology.
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9.2 Data set acquisition, processing and reconstruction
A three-dimensional data set is composed of anatomical information from multiple 2-D
cross-sectional images. For reconstruction of the mitral valve in adult patients,
transoesophageal echocardiography (TOE) is the preferred approach for 2-D image
acquisition since it offers a relatively stable site for the imaging probe and superior
resolution of the mitral valve apparatus. Images from a commercially available
multiplane TOE probe are interfaced with a 3-D computer system which incorporates
the steering logic for acquisition of a rotational data set and software for 3-D
reconstruction and display. With the mitral leaflets in the transverse mid-oesophageal
view, the multiplane TOE probe is usually rotated at 2 or 3 degree increments over 180
degrees to give 90 or 60 sequential 2-D cross sections which are then digitised to form a
conical data set [Salustri A, 1995], Optimal temporal and spacial registration is achieved
by ECG and respiratory gating. Off-line processing involves the conversion from polar
to cubic Cartesian co-ordinates and interpolation of missing information between 2D
slices.
From the resultant data set, novel 2-D cut planes in any orientation can be selected
(anyplane echo) and multiple parallel cross-sectional 2D slices can be generated in any
desired plane (paraplane echo). A volume rendered 3-D image of the mitral valve can be
reconstructed from any perspective (Figure 22). Threshold limits are used to separate
cardiac structures from blood pool and background. Brightness and shading provide
perception of depth. With the added dimension of time I am able to study in detail the
motion of the valve during the cardiac cycle.
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Figure 22 3DE of the normal mitral valve.
3D images reconstructed from the left atrial (A) and left ventricular (B) perspectives,
displaying fully the anterior (Ant) and posterior (Post) leaflets and their spacial relation
with the aorta and left atrial appendage (LAA).
9.3 Three-dimensional echocardiography in mitral stenosis
Three-dimensional echocardiography has a role in both the quantitative and qualitative
assessment of mitral stenosis. Paraplane 3-DE allows the 2-D short-axis slice in the
optimum plane of the orifice to be selected from the 3-D data set and the smallest
complete orifice can be directly measured by planimetry. Anterior leaflet calcification
often produces acoustic shadows which obscure the mitral orifice in the 2-D transthoracic
short axis plane. Three-dimensional TOE overcomes this problem by visualising the
mitral valve from behind such that acoustic shadows are cast into the left ventricle rather
than over the leaflet tips. There have been only two small studies, one in abstract form
only, investigating the use of 3-DE in measurement of mitral valve area [Chen Q
1997][Kasliwal R 1996]. In the next chapter I report the first in vitro study to validate the
accuracy of 3-D TOE for the measurement of mitral valve area.
The shape of the mitral valve leaflets proximal to the orifice has an impact on the flow
dynamics across a valve. 3-DE with stereolithographic modelling has been used to
demonstrate that flat shaped valves cause a higher pressure gradient for the same
anatomic area and flow rate compared with 'funnel' shaped valves [Gilon D 1996],
Thus, 3-DE provides insights into mitral leaflet geometry which could refine our
assessment ofmitral stenosis.
3-DE also appears to be of value in the assessment of patients undergoing balloon mitral
valvotonry, in particular for the evaluation of commissural morphology. Viewed from
the left atrium, 3-D reconstruction of mitral stenosis displays the restricted orifice,
thickened leaflet margins and prominent left atrial appendage (Figure 23a). In our
experience, the volume rendered 3-D display provides improved visualisation of mitral
commissural fusion, particularly when the leaflets are viewed from the perspective of
looking upwards from the left ventricle (Figure 23b). Following balloon valvotomy, 3-
DE also defines clearly the extent and site of commissural splitting which may be
symmetrical (Figure 23c) or eccentric (Figure 24). Other investigators have reported
improved imaging of the mitral commissures with 3-DE compared with 2-D TOE
[Salustri 1996]. Furthermore, 3-DE assessment of commissural splitting following
balloon inflation has been shown to relate to increase in mitral valve area.[Applebaum
1998]
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Figure 23 3DE of mitral stenosis.
3D images reconstructed from the left atrial (A) and left ventricular (B) perspectives.
The left ventricular view shows thickened leaflets with a restricted orifice due to
symmetrical commissural fusion. (C) shows the same valve after successful balloon
mitral valvotomy demonstrating increase in orifice area due to biliateral commissural
splitting.
Figure 24 3DE of mitral stenosis post balloon mitral valvotomy. 3D image
reconstructed from the left ventricular perspective. There has been splitting only of the
posteromedial (PM) commissure, the anterolateral commissure (AL) remains fused
resulting in an eccentric orifice. LVOT, left ventricular outflow tract.
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9.4 Limitations of three - dimensional echocardiography
The standard of the 3-D reconstructed display depends critically on the quality of the
original 2-D cross-sectional images. Until recently, in adult patients, this necessitated
TOE. However, the development of harmonic imaging has made it feasible to
reconstruct from a transthoracic rotational data set. Minor movements of either patient or
operator will distort the images and result in dropout which may be misinterpreted.
Image acquisition is gated to the ECG and respiration: a constant R-R interval and
respiratory pattern is ideally required. Variation in R-R interval will lead to a prolonged
acquisition time and tachycardia will result in fewer phases per cardiac cycle - both
leading to a suboptimal data set. This is often the case in atrial fibrillation, commonly
present in patients with mitral stenosis. Patients often have changing respiratory patterns,
particularly during intravenous sedation and this also prolongs acquisition time and
increases the likelihood ofmovement artefact.
Operator dependant changes in threshold settings, which define the tissue-blood
interface on the 3D rendered display, can affect the apparent mitral orifice. Therefore,
measurements on reconstructed images should be made with caution. Spontaneous echo
contrast in mitral stenosis hinders reconstruction of the valve from the left atrial
perspective, this can be minimised by reducing the probe frequency. Highly mobile
structures such as a ball valve thrombus, vegetations and ruptured chords are not well
seen. In our opinion, 3-DE has not improved visualisation of the mitral subvalvular
apparatus and areas of calcification are not apparent in the volume rendered display. At
present this technology provides information which compliments that gained from a
comprehensive 2-D and Doppler echocardiographic study.
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9.5 The future:
In the past, an important limitation of 3-DE has been the prolonged length of time
needed for raw data acquisition, data processing and image reconstruction which have
made intaoperative studies impractical. However, with improved ultrasound technology
and faster digital processing, these problems are being overcome. A rotational 3-D TOE
data set can be acquired, processed and displayed within 10 minutes and has been shown
to be feasible and useful in the intraoperative setting. 'Real time' 3-D transthoracic
probes have been developed and are already commercially available. These factors will
enhance the clinical applicability of 3-D echocardiography in the future.
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CHAPTER TEN
Measurement of mitral valve area using three-dimensional
transoesophageal echocardiography: in vitro validation
(BHF Junior Research FellowshipFS/98072)
10.1 Background
Accurate measurement of mitral valve area (MVA) is essential for the management of
patients with mitral stenosis. Conventionally, mitral stenosis is quantified by 2D and
Doppler echocardiography and also by invasive haemodynamic catheter data. However,
as I have discussed previously (section 1.9), all these techniques have important
limitations and are imprecise. As yet there is no reliable 'gold standard' for the
measurement ofmitral valve area.
Three-dimensional echocardiography (3-DE) overcomes the limitations of image plane
positioning inherent in 2-DE. By selecting the cut plane in the optimum orientation to
the plane of the orifice 3-DE allows more precise planimetry of the limiting mitral valve
orifice
There have been only two previous clinical studies, one published only in abstract form,
of the application of 3-DE for the measurement of MVA [Chen Q 1997][Kasliwal R
1996] I report the first in vitro study to validate the accuracy of 3-D TOE in the
measurement ofMVA.
10.2 Aims:
1.To determine the accuracy and reproducibility of three-dimensional transoesophageal
echocardiography (3-D TOE) in the measurement ofmitral valve area (MVA) using an
in vitro model




10.31 Preparation of valves
Forty mitral valves were studied. Thirty five had been isolated from porcine hearts and
anterolateral and posteromedial commissures were glued to simulate mitral stenosis. The
commissures were glued to varying degrees in order to vary the shape and plane of the
orifice and to achieve a gradation of stenosis severity. The latter five valves had been
surgically excised from patients with mitral stenosis undergoing valve replacement. All
valves were fixed with leaflets in the open (diastolic) position in formalin for 48 hours.
10.32 Three-dimensional Echocardiography
Data set acquisition.
The prepared valves were mounted on perspex and scanned in a water bath (Figure 25).
A 7.5 MHz multiplane transoesophageal echo probe (Acuson TE-V5M) was positioned
on the atrial aspect of the valve to obtain a transverse view of the leaflets. Video output
from the ultrasound scanner (Acuson 128 XP/10) was interfaced with the 3-D
reconstruction system (Tomtec Echoscan, Munich). A rotational 3-D data acquisition
was performed as previously described (Section 2.6).
Analysis of the 3-D data set
The mitral valve was viewed in the 2-D transverse image plane with clear visualisation
of the leaflet tips. A line of intersection was positioned at the tips of both mitral leaflets
in the plane of the orifice. This resulted in a short axis image of the valve with optimal
orientation to the orifice. Multiple parallel short axis slices at 1 mm intervals
incorporating the leaflet tips to the mitral annulus were generated using the paraplane
facility. The optimal short axis slice defining the smallest complete orifice was selected
for planimetry using Tom Tec software (Figure 26).
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Figure 25 Apparatus for three-dimensional transoesophageal data set acquisition
Glued mitral commissures
Figure 26 Planimetry of the optimal 2-D short axis image in the plane of the orifice
using paraplane 3-D echo
Finally, a volume rendered 3-D image of the valve was displayed. This is based on
threshold values set by the operator to identify borders of the object of interest and to
separate cardiac structures from the blood pool and background. The images were
reconstructed in 2 planes (viewed from left atrial and left ventricular perspectives) and
compared with the actual anatomy shown by photographic images of the valve.
10.33 Determination of reference standard valve area.
The actual or reference standard MVA was determined using a digital photographic
technique. The mitral valve was held above a standard flat-bed document scanner
(UMAX, Astra 1220P). A parallel light beam from a source 1 metre above was directed
through the valve to create a silhouette of the orifice on the surface of the scanner. The
valve was angulated in order to project the maximum orifice area. In this position, the
valve was scanned at 300 pixels per inch and the orifice area was determined by
measurement of pixel intensity in the segmented area of interest using a commercially
available computer software package (PaintShop Pro 5, JASC software).
The accuracy of this technique was assessed using 12 cylindrical phantoms of known
cross-sectional area ranging from 0.19 to 5.02 cm2. The digital scanner derived areas
correlated closely with the actual phantom areas (Mean difference +/- 2SD = -0.004 +/-
0.084 cm2) and was deemed to be a reliable reference standard.
Valve areas measured by 3-DE and the reference standard technique were performed by
independent operators.
10.4 STATISTICS
The correlation between MVA determined by 3-DE and the reference standard technique
was studied using the Pearson correlation coefficient and limits of agreement assessed
by the method described by Bland and Altman.
129
10.5 RESULTS
10.51 Interobserver variability ofMVA by 3-DE
Off-line analysis of each 3-DE data set was performed by 2 independent operators with
good interobserver agreement: Pearson Correlation Coefficient r = 0.986.
10.52 MVA by 3-DE versus reference standard
In 40 mitral valves, MVA determined by paraplane 3-DE ranged from 0.35 - 4.1 cm2
(mean +/- SD: 1.39 +/- 0.80). The reference standard areas ranged from 0.25 - 4.0 cm2
(Mean +/- SD: 1.34+/- 0.79). There was a very good correlation between the areas
determined by 3-DE and by the reference standard technique (r = 0.986) with close
limits of agreement : Mean difference +/- 2SD (Bland Altman) = -0.05 +/- 0.34 cm2
(Figure 27).
In a heavily calcified human mitral valve, 3-D TOE allowed clear visualisation of the
orifice. Despite anterior leaflet calcification, paraplane echo enabled the operator to
visualise the optimum 2-D short axis plane of the valve for planimetry without limitation
from acoustic shadowing (Figure 28).
10.53 Analysis of 3-D volume rendered images
The 3-D reconstructed images were compared with digital photographs of the same
valve. The 3-D images displayed accurately the geometry of the mitral valve leaflets and
orifice from both atrial and ventricular perspectives (Figure 29).
Figure 27 Bland Altman plot of the difference between MVA determined by 3-DE and
reference standard area with mean difference and 95% confidence intervals
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figure 27 Bland Altman Plot of the difference between MVA determined by 3-DE and













Standard reference area (cmsq)
Figure 28 Calcified excised human mitral valve photographed from the left atrial
perspective (A). Anterior leaflet calcification is shown on the 2-D transverse image (B).
The 3-D data set allows selection of the optimum 2-D short-axis plane of the orifice for
planimetry (C) without limitation from acoustic shadowing.
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Figure 29 Comparison between photographic (left) and 3-D reconstructed (right) images
of four mitral valves from atrial (top) and ventricular (bottom) perspectives. Figures A
and B show excised human valves, C and D show prepared porcine valves.
Discussion
There is an increasing demand for more accurate quantitative assessment of heart valve
disease. Conventional echocardiography provides excellent qualitative information
regarding mitral valve anatomy but lacks accuracy and reproducibility for measurement
of mitral valve area. In section 1.7, we have seen how 2-D transthoracic
echocardiography is limited by image plane positioning and Doppler pressure half-time
becomes unreliable during changes in heart rate and loading conditions. Cardiac
catheterisation is still considered the 'gold standard' but is also imprecise and varies
with heart rate, rhythm, changes in LV compliance and severity of mitral reflux. Further
errors are introduced when the pulmonary artery wedge pressure is used as an indirect
measurement of left atrial pressure, or if cardiac output is estimated rather than directly
measured.
By eliminating assumptions about image plane positioning and LV geometry which are
inherent in conventional 2-D imaging, 3-DE provides a more precise approach to
quantitative analysis. Three-dimensional echo allows 2-D cut planes of any orientation
to be selected from the original data set (anyplane echo) and can generate multiple
parallel 2-D slices in a desired plane (paraplane echo). These facilities could allow
precise localisation of the limiting mitral valve orifice and accurate planimetry of mitral
valve area. However, there have been only two published studies of the use of 3-DE for
measurement ofMVA. Chen et al [Chen 1997] assessed 15 patients with mitral stenosis
and demonstrated that MVA measured by paraplane 3-DE correlated more closely with
the Doppler PHT derived area compared with 2-D planimetry (r=0.98 vs r=0.89).
Acquisition was performed using transoesophageal and transthoracic echo and
satisfactory analysis of 3D-E data sets was possible in all patients including those with
atrial fibrillation and mild leaflet calcification. However, Doppler PHT is itself an
imperfect technique for determining MVA and so this study is limited by its use of
Doppler PHT as the gold standard. The second study is published in abstract form only
[Kasliwal 1996]. In this report 3-D transoesophageal echo was superior to 2-D
transthoracic echo for planimetry ofMVA in 54 patients when compared with the valve
area measured at surgery with calibrated dilators. This study is limited because surgical
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dilators have a circular cross section whereas the mitral orifice is often eccentric in
shape. Also measurements of orifice area made at surgery may be quite different to the
actual mitral valve area in the physiological setting of a beating heart.
I report the first in vitro study to validate the accuracy of 3-D transoesophageal for
measurement of mitral valve area using a reliable standard reference for comparison.
Our technique for locating the limiting mitral valve orifice is similar to that described in
the previous studies. MVA measured by 3-DE was reproducible between operators and
correlated very well with the standard reference area with close limits of agreement.
Additionally, the volume rendered 3-D image provided accurate qualitative information
regarding the valve leaflet and orifice shape.
Study limitations
I have assessed the accuracy of 3-D TOE in ideal conditions which allow rapid
acquisition of an optimal 3-D data set. Our in vitro model avoided the problems of
artefact due to patient and probe movement and did not require respiratory or R-R
interval gating which prolong the acquisition time in the clinical setting. Severe leaflet
thickening and calcification might limit the definition of the orifice margins; this could
not be assessed in the porcine valves. Further clinical studies are required to evaluate the
general applicability of 3-DE in cardiological practice.
TOE is a semi-invasive procedure which would not be justified for the routine
measurement of mitral valve area. Transthoracic 3-DE is a more realistic application of
this technique and the recent development of 'real-time' transthoracic 3-DE makes this a
very practical proposition. The accuracy of the paraplane echo technique needs to be
confirmed using these new transthoracic scanners.
Conclusions
3-D TOE is an accurate and reproducible technique for measurement ofmitral valve area
in vitro. This technology is rapidly expanding. 3-D software is being integrated into
modern echo machines, faster and more highly automated image processing is becoming
available and 'real time' 3-D transthoracic probes are being developed. This will
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enhance the clinical applicability of 3-DE which could become the gold standard for




Rheumatic mitral stenosis remains the commonest cause of acquired heart disease in
children and young adults worldwide. With medical treatment alone, severe mitral
stenosis leads to progressive deterioration and death, with only 15% of such patients
remaining alive at 5 years. Until the mid 1980s, cardiac surgery was the only option for
these patients. In 1984, Inoue introduced balloon mitral valvotomy as a new
percutaneous technique which produced equivalent results to surgical commissurotomy
without the risks of thoracotomy and general anaesthesia. In contrast to aortic
valvuloplasty which is now seldom performed except as a palliative treatment, BMV has
been widely used as an alternative to cardiac surgery. The success of BMV in young
patients with pliant valves and predominant commissural fusion has been well
documented and for such patients this technique has become the treatment of choice.
The disappearance of rheumatic fever in the developed world has dramatically changed
the demographics of valvular heart disease. Patients presenting with mitral stenosis to
Western centres such as ours are typically elderly. The clinical and anatomical
characteristics of this population have been less extensively studied. Furthermore,
experience of BMV in this population is limited and there have been no randomised
trials of BMV versus surgery in the elderly. Consequently, the role of BMV in older
patients remains controversial.
In a centre with the largest experience of BMV in the UK, I report on a series of 405
consecutive patients, mean age 60.7 years, with diverse clinical and anatomical
characteristics in whom BMV offered both definitive and palliative treatment options.
Symptomatic outcome was recorded in 300 patients over 10 years, representing the
largest reported long term study of this age group. Older patients had more severe,
symptomatically limiting mitral stenosis but with thickened, calcified valves less
suitable for BMV. However, they were also at higher risk from cardiac surgery with
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overall 26% being judged as inoperable (59% of those >70). BMV in this population
was feasible and safe. The procedure resulted in significant immediate haemodynamic
improvement (58% had final MVA>1.5 cm2 without severe MR) and symptomatic gain
(81% had improved by at least NYHA class at 3 months). Functional benefit was
sustained for a reasonable period of time given the extensive comorbidity (61%, 52%,
and 42% remained symptomatically improved without MVR at 1, 3 and 5 years
respectively). In the frail elderly, BMV offered short term palliation with a low risk of
complications. Even a suboptimal improvement in valve area translated into
symptomatic benefit which may be sufficient for many individuals to retain their
independence.
Long term symptomatic success from BMV could be predicted from the quality of the
initial result (MVA>1.5cm2 without severe MR). This was determined primarily by
valve anatomy which can be assessed crudely by grading fluoroscopic calcification and
more precisely by echocardiographic scoring of leaflet, subvalvar and most importantly
commissural morphology. Careful echocardiographic assessment of mitral stenosis is
therefore critical to the selection ofpatients for BMV. Furthermore, careful evaluation of
post-procedural valve area and mitral regurgitation is important to identify those likely
to deteriorate rapidly unless MVR is offered.
Evaluation of mitral stenosis was the first clinical application of cardiac ultrasound
which remains the most important method for the assessment of patients undergoing
BMV. Since commissural splitting is the dominant mechanism underlying BMV,
commissural morphology should be an integral part of valve assessment. The Wilkins
Echo Score is a useful screening tool used widely to select patients for BMV. However,
it does not include commissural assessment. Severe degenerative change in the leaflets
and subvalvar apparatus develop in parallel with commissural calcification and patients
with very high Wilkins Scores ('bad Wilkins valves') have an adverse outcome.
However, one third ofpatients with a low Wilkins Score ('good Wilkins valve') failed to
achieve a satisfactory haemodynamic result and tended to deteriorate rapidly after BMV.
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Seventy eight percent of such patients were judged operable and might have been better
served by MVR.
Commissural calcification affected nearly one third of patients referred with mitral
stenosis, increasing in males, the elderly and those with more severe and symptomatic
stenosis. Transthoracic echocardiographic assessment of commissural calcification
significantly improved the prediction of immediate outcome in 'good Wilkins valves'
and was shown to be the most useful anatomical factor for prediction of long term
outcome. Patients with absent or minimal commissural calcification (Commissural
calcification Grade <2) and little other degenerative change in the leaflets or subvalvular
apparatus (Wilkins Scores <8) were ideally suited to BMV and more likely to enjoy a
successful immediate result (68% final MVA >1.5 without MR) and longer term benefit
(1,3 and 5 and 7 year survival with improved symptoms and no MVR 84%, 77%, 68%
and 60% respectively, median 7.24 years).
Transoesophageal echocardiography is performed routinely prior to BMV primarily to
exclude left atrial thrombus. However, using a novel scanning technique I have shown
that TOE also offers a more accurate and systematic evaluation of mitral commissural
fusion and calcification. The absence of non-calcified (splittable) commissural fusion
was very strongly predictive of adverse immediate outcome and superior to the currently
accepted Wilkins Score. This role of TOE has not been previously demonstrated and
could improve case selection, particularly in those who are poor transthoracic subjects.
Evolving echo technology may help to refine our assessment of mitral stenosis in the
future. Three-dimensional echocardiography has provided a new insight into complex
cardiac structures such as mitral valve. By overcoming problems of image plane
positioning inherent in 2-D echo it provides a highly accurate method for planimetry of
mitral valve area in vitro. This application needs to be studied in the clinical setting
using real time transthoracic scanners and if problems of speed of acquisition, image
quality and motion artefact are overcome, this could become the 'gold standard' for
quantification of mitral stenosis. By displaying the valve leaflets in their entirety from
any perspective, 3-D echo offers a better display of commissural fusion and splitting
which may help to assess the results ofBMV. However, commissural calcification is not
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identified. Whether 3-D echo adds significantly to the morphological assessment gained
by conventional 2-D echocardiography in patients undergoing BMV remains to be seen.
The report of the Royal College of Physicians of London on 'Cardiological Intervention
in Elderly Patients'[RCP, 1991] stated that "The goals of medical intervention are
improvement in function and postponement of disability, so extending the period of
active independent life". Percutaneous balloon valvotomy can help to achieve this for
many elderly patients. Current methods of echocardiographic assessment are imperfect
predictors of outcome in a diverse, elderly population and need refinement. In those
patients who are fit for surgery, albeit at enhanced risk, I was able to improve the case
selection for BMV by including detailed evaluation of commissural morphology using
both transthoracic and transoesophageal echo. Those with a high Wilkins Score or
unfavourable commissural morphology are less likely to gain longterm success from
BMV and should be offered MVR. In those frail elderly who are unfit for surgery,
cautious balloon inflation accepting a suboptimal reduction in gradient may still offer
short term palliation of symptoms at low risk and should be attempted if there is any
prospect of commissural splitting. Elderly patients with severe mitral stenosis should
therefore be referred to a cardiac centre for detailed echocardiographic assessment.
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APPENDIX I




1 Highly mobile , only Minimal thickening Leaflets near normal Single area of
leaflet tips restricted just below leaflets thickness (4-5 mm) echo brightness
2 Leaflet mid and base Thickening of Mid-leaflets normal, Scattered areas
move normally chordae extending to considerable of brightness
one third chordal thickening of leaflet confined to
length margins (5-8mm) leaflet margins
3 Valve moves forward Thickening extends Thickening extends Brightness
in diastole mainly to distal third of through entire leaflet extends to mid
from base chords (5-8 mm) portion of
leaflets
4 No/minimal forward Extensive thickening Considerable Extensive
movement of leaflets and shortening of all thickening of all brightness
in diastole chordal structures leaflet tissue (>8-10 throughout much
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